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Abstract
Adverse cardiac remodeling after myocardial infarction (MI) causes structural and functional
changes in the heart leading to heart failure. The initial post-MI pro-inflammatory response
followed by reparative or anti-inflammatory response is essential for minimizing the myocar-
dial damage, healing, and scar formation. Bone marrow–derived macrophages (BMDMs)
are recruited to the injured myocardium and are essential for cardiac repair as they can
adopt both pro-inflammatory or reparative phenotypes to modulate inflammatory and repar-
ative responses, respectively. Yes-associated protein (YAP) and transcriptional coactivator
with PDZ-binding motif (TAZ) are the key mediators of the Hippo signaling pathway and are
essential for cardiac regeneration and repair. However, their functions in macrophage polar-
ization and post-MI inflammation, remodeling, and healing are not well established. Here,
we demonstrate that expression of YAP and TAZ is increased in macrophages undergoing
pro-inflammatory or reparative phenotype changes. Genetic deletion of YAP/TAZ leads to
impaired pro-inflammatory and enhanced reparative response. Consistently, YAP activation
enhanced pro-inflammatory and impaired reparative response. We show that YAP/TAZ pro-
mote pro-inflammatory response by increasing interleukin 6 (IL6) expression and impede
reparative response by decreasing Arginase-I (Arg1) expression through interaction with
the histone deacetylase 3 (HDAC3)-nuclear receptor corepressor 1 (NCoR1) repressor
complex. These changes in macrophages polarization due to YAP/TAZ deletion results in
reduced fibrosis, hypertrophy, and increased angiogenesis, leading to improved cardiac
function after MI. Also, YAP activation augmented MI-induced cardiac fibrosis and remodel-
ing. In summary, we identify YAP/TAZ as important regulators of macrophage-mediated
pro-inflammatory or reparative responses post-MI.
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Introduction
Myocardial infarction (MI) and the risk of subsequent heart failure are a major global health
burden with significant mortality and morbidity. MI occurs from obstructed coronary artery,
causing inadequate oxygen and nutrient supply to the heart muscle or myocardium, leading to
tissue hypoxia and cell death. Cardiomyocyte death triggers an acute inflammatory response
through macrophage recruitment to the infarcted area, which ultimately activates reparative
pathways necessary for preventing further loss of cardiomyocytes, fibrotic scar formation, and
restoring tissue integrity [1–3]. Majority of these macrophages are derived from differentiated
peripheral blood monocytes from the bone marrow and spleen. These macrophages orches-
trate the myocardial repair response by secreting pro-/anti-inflammatory, pro-angiogenic, and
pro-reparative factors, as well as removing dead cells through phagocytosis [4–9]. The diverse
functions of macrophages in infarcted hearts are partially attributed to their ability to adopt
different phenotypes and polarization status in response to environmental stimuli. Based on
their inflammatory properties, macrophages are classified into 2 major groups: classically acti-
vated pro-inflammatory macrophages and alternatively activated anti-inflammatory/repara-
tive macrophages [10–12]. Reparative macrophages can be further subdivided into M2a, M2b,
M2c, and M2d [13]. Pro-inflammatory macrophages, responsible for stimulating an inflamma-
tory response, dominate the heart at day 1 to 3 post-MI and secrete high level of pro-inflamma-
tory cytokines and chemokines such as interleukin (IL)-6, IL-1β, IL-12β, Rantes, monocyte
chemoattractant protein-1 (MCP-1), and tumor necrosis factor alpha (TNFα). In contrast,
reparative macrophages, responsible for preserving the structural integrity of the injured ven-
tricle by promoting cardiac repair through myofibroblasts induction, collagen deposition, and
neovascularization, dominate the heart at day 5 to 7 post-MI and secrete high level of anti-
inflammatory cytokines and angiogenic factors such as IL-10, vascular endothelial growth fac-
tor (VEGF), fibroblast growth factor 2 (FGF2), and transforming growth factor beta (TGFβ)
[3,11,14–18]. Among other markers, Arginase-I (Arg1), the enzyme that is involved in l-argi-
nine/nitric oxide (NO) metabolism, mannose receptor CD206, chitinase-like lectin YM1, and
resistin-like secreted protein FIZZ1 are also associated with the reparative phenotype [11,19–
23]. A fine balance between pro-inflammatory and reparative macrophage response is essential
for optimal repair as enhanced or persistent pro-inflammatory response can delay the repara-
tive macrophage-mediated repair response and exacerbate adverse ventricular remodeling.
Growing evidence suggests that a shift from pro-inflammatory to reparative phenotype has a
positive effect on cardiac repair and function post-MI [24–28]. Thus, identifying new factors
involved in modulating pro-inflammatory/reparative responses will provide novel therapeutic
targets that may prevent adverse cardiac remodeling and heart failure post-MI.
Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif
(TAZ) are the main downstream transcriptional regulators of the Hippo signaling pathway.
Extensive preclinical studies have established the role of the Hippo pathway components in
cardiac development, regeneration, and cellular homeostasis. The growing evidence suggests
that they are also involved in regulating biological processes other than growth and develop-
ment, such as immune response [29–40]. For example, Hippo signaling components modulate
tumor microenvironment through interactions with immune cells such as macrophages. Simi-
larly, YAP-driven CXCL5 produced by prostate cancer cells can lead to infiltration of the mye-
loid-derived suppressor cells to the tumor site [30]. YAP functions downstream of PRKCI
oncogene and induces TNFα expression, which promotes myeloid-derived suppressor cells
and inhibits cytotoxic T cell infiltration in ovarian carcinomas [31]. YAP also directs the
recruitment of tumor-associated macrophages, essential for immune evasion and tumorigene-
sis [32,33]. Similar to YAP, TAZ also promotes inflammatory cytokine production and
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macrophage infiltration [34]. The Hippo pathway components also modulate the immune
response against viral or bacterial infections [29,35–39]. Apart from directing the innate
immune response, the Hippo pathway components also modulate the adaptive immune
responses in multiple pathological conditions. For example, we recently demonstrated that
YAP/TAZ expression in the epicardium is essential not only for coronary vasculature develop-
ment but also for limiting the inflammatory and fibrotic response during post-MI recovery
phase [41,42]. Despite the well-established role of Hippo signaling components in non-
immune cells regulating the inflammatory response, very little is known about its functions in
immune cells [43–45]. The role of Hippo signaling components in immune cells, particularly
in macrophage polarization and macrophage-mediated cardiac inflammation, remodeling,
and repair response post-MI is not well established.
In the present study, we identified YAP/TAZ as essential regulators of macrophage polari-
zation and functions. In response to both pro-inflammatory or reparative stimuli, YAP and
TAZ expressions are increased in macrophages. Knockdown or conditional genetic deletion of
YAP/TAZ in macrophages leads to decreased expression of pro-inflammatory genes and
increased expression of anti-inflammatory/reparative genes. Our results demonstrate that
YAP/TAZ act as an activator in pro-inflammatory macrophages while behaving as a repressor
in reparative macrophages. YAP/TAZ promote pro-inflammatory phenotype by directly regu-
lating interleukin 6 (IL6) promoter activity or through the p38-dependent MAPK pathway.
While during reparative phenotype, YAP/TAZ repress Arg1 expression by binding to its pro-
moter and recruiting histone deacetylase 3 (HDAC3)-nuclear receptor corepressor 1 (NCoR1)
repressor complex. We further demonstrate that YAP/TAZ-deficient mice show improved car-
diac remodeling and function after MI, evident by reduced cardiac fibrosis, reduced cardiac
hypertrophy, and improved tissue angiogenesis. Consistently, overexpression of a constitu-
tively active YAP mutant (YAP5SA) showed opposite effects on macrophage polarization lead-
ing to increased fibrosis and adverse remodeling of the heart post-MI. Together, our findings
demonstrate that YAP/TAZ modulate post-MI inflammatory and reparative response by regu-
lating macrophage polarization.
Results
YAP/TAZ expression is enhanced in pro-inflammatory macrophages
To determine whether YAP/TAZ are involved in macrophage polarization, we treated mouse
bone marrow–derived macrophages (BMDMs) and peritoneal macrophages (PMs) with lipo-
polysaccharide (LPS)/interferon gamma (IFNγ) (pro-inflammatory macrophage-stimuli) for 0
to 12 hours and prepared protein extracts for whole cell lysate to perform western blot analysis.
In BMDMs, the expression of YAP was significantly enhanced after 6 hours of stimulation and
remained steady for 12 hours. Similarly, LPS/IFNγ treatment also increased YAP phosphoryla-
tion at S127 in BMDM cells (Fig 1A). In PMs, YAP expression was significantly increased after
6 hours post-treatment and remained steady for 12 hours (Fig 1B). Similar to YAP, TAZ
expression was also increased after 6 hours of stimulation with LPS/IFNγ and remained steady
for 12 hours (Fig 1A and 1B). The pro-inflammatory macrophage phenotype was confirmed
by the presence of pro-inflammatory marker IL6 (Fig 1A and 1B). Since YAP/TAZ act in the
nucleus, we furthermore measured the nuclear presence of YAP/TAZ together with cyto-
plasmic expression of pYAP in BMDMs after LPS/IFNγ treatment for 8 and 12 hours. Western
blot analysis revealed a significant increase of YAP, TAZ, and pYAP protein levels with pro-
inflammatory macrophage-stimuli (S1 Fig). To determine whether LPS/IFNγ treatment
resulted in the formation of pro-inflammatory and not reparative phenotype, we also mea-
sured the expression of reparative markers and observed no significant change or decrease in
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the Tgfβ and Vegf gene expression levels. No significant change in the TGFβ protein level was
detected (S2A and S2B Fig). Similarly, to determine whether IL4/IL13 (reparative macro-
phage-stimuli) treatment resulted in the formation of the reparative and not pro-inflammatory
phenotype, we measured the expression of pro-inflammatory marker IL6 and observed no
change in the protein levels (S2C Fig). Collectively, pro-inflammatory macrophage-stimuli
strongly enhanced both YAP and TAZ protein levels, suggesting a role for YAP/TAZ in mac-
rophage polarization.
To better understand the role of YAP and TAZ in macrophage polarization, we transfected
short interfering RNA (siRNA) to knockdown mouse YAP and TAZ in wild-type BMDMs.
The knockdown efficiency of YAP and TAZ in BMDMs was confirmed by western blot analy-
sis (Fig 1C and S3A Fig). Compared with BMDMs transfected with control siRNA, YAP and
TAZ knockdown BMDMs had reduced levels of pro-inflammatory markers such as IL6 and
nitric oxide synthase 2 (Nos2), after LPS/IFNγ treatment (Fig 1C and S3A Fig). Consistent
with changes in protein levels, mRNA levels of pro-inflammatory genes such as IL6, IL1β,
IL12β, and Nos2 were also decreased in YAP knockdown BMDMs when compared with con-
trols (Fig 1D). Likewise, compared to control siRNA, TAZ knockdown in BMDMs signifi-
cantly reduced the mRNA levels of IL1β, IL12β, and Nos2 (S3B Fig). Similar changes in IL6,
IL1β, and Nos2 expressions were observed when wild-type BMDMs were treated with Hippo
signaling inhibitor verteporfin (VP) in the presence of LPS/IFNγ (S3D Fig). In contrast,
knockdown of YAP in the presence of IL4/IL13 resulted in significant up-regulation of anti-
inflammatory/reparative macrophage marker genes such as Arg1 and early growth response 2
(Egr2). However, no significant change in cluster of differentiation 206 (Cd206), Ym1, and
found in inflammatory zone 1 (Fizz1) expression was observed (Fig 1E). Interestingly, knock-
down of TAZ in the presence of IL4/IL13 increased the mRNA level of Arg1, Ym1, and Fizz1
(S3C Fig). Together, these results suggest that YAP and TAZ play an important role in macro-
phage polarization.
Global changes in gene expression due to YAP/TAZ deletion in BMDMs
To further establish the role of YAP/TAZ in macrophage polarization, we generated myeloid
cell-specific YAP/TAZ double knockout mice by crossing YAPflox/flox;TAZflox/floxmice with
lysozyme-cre (LysMcre) mice that drive Cre recombinase activity in myeloid lineages, including
macrophages. YAPflox/flox;TAZflox/flox and LysMcre;YAPflox/flox;TAZflox/floxmice are referred to as
control and YAP/TAZ double knockout (YAP/TAZ-dKO), respectively. To determine the dele-
tion efficiency, we isolated BMDMs from control and YAP/TAZ-dKO mice and performed
real-time quantitative reverse transcription PCR (qRT-PCR) and western blot for YAP and
TAZ. YAP and TAZ expression both at RNA and protein levels were significantly reduced in
Fig 1. YAP/TAZ expression is enhanced in pro-inflammatory macrophages. (A and B) Western blot analysis for YAP, pYAP (S127), TAZ, and IL6 was
performed using total lysates from wild-type BMDMs (A) and PMs (B) treated with LPS/IFNγ for 0 to 12 hours as indicated. β-actin or vinculin is shown as a
loading control. The relative protein expression was quantified. (C–E) BMDMs were isolated from wild-type mice and transfected with control or YAP siRNA
for 72 hours, followed by LPS/IFNγ or IL4/IL13 stimulation for 16 hours. Cell lysates were prepared for western blot and qRT-PCR analysis. (C) Western blot
analysis for YAP, IL6, and Nos2 was performed using total lysates from wild-type BMDMs transfected with control or YAP siRNA. β-actin is shown as a
loading control. The relative protein expression was quantified. (D) qRT-PCR for pro-inflammatory marker genes IL6, IL1β, IL12β, Nos2, and Fpr2 using RNA
isolated from wild-type BMDMs transfected with control or YAP siRNA and stimulated with LPS/IFNγ. (E) qRT-PCR for reparative/anti-inflammatory marker
genes Arg1, Egr2, Cd206, Ym1, and Fizz1 using RNA isolated from wild-type BMDMs transfected with control or YAP siRNA and stimulated with IL4/IL13.
Data are shown as the mean ± SEM, n = 3 for each experimental group. Gene expression data were normalized with the reference gene Gapdh, and results are
represented as fold change relative to the control treatment. For numerical raw data, please see S1 Data. Arg1, Arginase-I; BMDMs, bone marrow–derived
macrophages; Cd206, cluster of differentiation 206; Egr2, early growth response 2; Fizz1, found in inflammatory zone 1; Fpr2, formyl peptide receptor 2;
Gapdh, glyceraldehyde-3-phosphate dehydrogenase; IFNγ, interferon gamma; IL, interleukin; LPS, lipopolysaccharide; Nos2; nitric oxide synthase 2; NS, non-
significant; PMs, peritoneal macrophages; pYAP, phosphorylated YAP; qRT-PCR, real-time quantitative reverse transcription PCR; siRNA, short interfering
RNA; TAZ, transcriptional coactivator with PDZ-binding motif; YAP, yes-associated protein.
https://doi.org/10.1371/journal.pbio.3000941.g001
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YAP/TAZ-dKO BMDMs, suggesting efficient deletion (S4 Fig). To determine the purity of iso-
lated BMDMs and PMs, we performed flow cytometry using cluster of differentiation 11B-
fluorescein isothiocyanate (CD11b-FITC) and Allophycocyanin (APC) anti-mouse F4/80 anti-
bodies. We observed nearly 99.69% and 97.63% purity for BMDMs and PMs, respectively
(S5A and S5B Fig). Considering YAP/TAZ regulates organ size by modulating cell prolifera-
tion, we performed Ki67 immunostaining on BMDMs isolated from control and YAP/TAZ-
dKO mice. Consistent with previous reports, we did not observe any significant change in
macrophage proliferation (S6A and S6B Fig) [45,46]. Similarly, macrophage migration was not
affected in both control and YAP/TAZ-dKO BMDMs (S6C and S6D Fig).
To identify downstream targets of YAP/TAZ in macrophage polarization, we performed
RNA sequencing (RNA-seq) analysis on BMDMs isolated from 2- to 3-month-old control and
YAP/TAZ-dKO mice and treated them with or without LPS/IFNγ (Fig 2). The average RNA-
seq depth was 30 million reads per sample. Paired-end RNA-seq reads from each sample were
aligned to the mouse reference genome with an average mapping rate of 81%. Genes with
absolute log fold change>1.0 and false discovery rate <5% were considered as differentially
expressed. We analyzed the RNA-seq data by comparing control untreated to LPS/IFNγ
treated BMDMs, YAP/TAZ-dKO untreated to LPS/IFNγ treated BMDMs, and control to
YAP/TAZ-dKO BMDMs, both treated with LPS/IFNγ. We identified 3,253, 3,191, and 137 dif-
ferentially expressed genes, respectively (Fig 2A and 2B, S1 FCS file). We also identified 86
genes that were differentially expressed and were common among the 3 groups (Fig 2A). Heat
map of top 50 differential genes between LPS/IFNγ treated control to YAP/TAZ-dKO groups
showed decreased expression of many pro-inflammatory genes such as IL6, Il12b, C-C chemo-
kine receptor type 7 (Ccr7), etc. (Fig 2B). Pathway enrichment analysis identified significant
enrichment of genes involved in regulating inflammation such as cellular response to cytokine
stimulus, inflammatory response, and cytokine-mediated signaling (Fig 2C). MA plots showed
that immune, especially pro-inflammatory macrophage marker genes such as IL6, IL1β, and
IL12β were significantly down-regulated in YAP/TAZ-dKO cells compared with controls (Fig
2D and S7 Fig).
YAP/TAZ deficiency impairs pro-inflammatory macrophage phenotype
RNA-seq results showed significant changes in immune gene expression after YAP/TAZ dele-
tion in the macrophages. To further characterize the pro-inflammatory macrophage polariza-
tion defects in YAP/TAZ-dKO, we isolated BMDMs from control and YAP/TAZ-dKO mice
and treated them with/without LPS/IFNγ for 12 hours. Total RNA was then isolated after for
qPCR analysis. In unstimulated conditions, YAP/TAZ-dKO BMDMs exhibited reduced
expression of pro-inflammatory genes (IL1β and IL12β) (Fig 2E). Similarly, in the presence of
LPS/IFNγ, expression of pro-inflammatory genes such as IL6, IL1β, IL12β, Nos2, TNFα, C–C
motif chemokine ligand 2 (Ccl2), and Rantes was significantly decreased in YAP/TAZ-dKO
BMDMs (Fig 2E). Additionally, YAP/TAZ-deficient BMDMs showed a markedly reduced
level of NO after LPS/IFNγ treatment, suggesting a reduced inflammatory response (Fig 2F).
To determine whether the changes in gene expression are translated to the protein level, we
performed western blot for IL6, IL1β, and Nos2. We observed reduced IL6, IL1β, and Nos2
protein levels in YAP/TAZ-dKO BMDMs, when compared with control BMDMs after LPS/
IFNγ treatment (Fig 3A). To determine the molecular mechanism by which YAP/TAZ may
affect the expression of IL6, we assessed the activation status of key components of the Toll-
like receptor 4 (TLR4)-transforming growth factor beta-activated kinase 1 (Tak1)-nuclear fac-
tor kappa B (NF-kB)/mitogen-activated protein (MAP) kinases pathway. Upon activation,
TLR4 recruit adaptor protein myeloid differentiation primary response 88 (MyD88) and
PLOS BIOLOGY Hippo pathway modulating macrophage polarization in injured heart
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activate common upstream activator Tak1 of NF-kB and MAP kinase pathway [47]. We found
that there was a significant reduction of phosphorylated Tak1 protein level in YAP/TAZ-dKO
BMDMs after 15 minutes of LPS/IFNγ treatment (Fig 3B). However, we did not observe any
changes in the phosphorylated level of inhibitor of nuclear factor kappa-αβ-kinase (IKKαβ)
(Fig 3B). Consistently, YAP did not affect the activity of NF-кB luciferase reporter in unstimu-
lated condition suggesting that YAP/TAZ mediated activation of IL6 in macrophage maybe
not dependent on the NF-kB signaling pathway (S8A Fig). Next, we tested the key components
of MAPKs and observed significant but transient reduction in the levels of phosphorylated c-
Jun N-terminal kinase (JNK), p38, and extracellular signal-regulated kinase 1/2 (Erk1/2) in
YAP/TAZ-deficient macrophages after 15 minutes of LPS/IFNγ stimulation (Fig 3B).
Considering YAP and TAZ are transcriptional coactivators and interact with Tead (Tran-
scriptional enhanced associate domain) transcription factors to regulate target gene expres-
sion, we next assessed whether YAP/TAZ regulate IL6 expression at the transcription level by
directly binding and modulating IL6 promoter activity. We analyzed the promoter of IL6 and
identified 10 consensus Tead-binding sequences (TBSs) within the 2Kb promoter fragment
(Fig 3C and 3D). We then PCR-amplified the IL6 promoter fragment (2kb), cloned into a
luciferase reporter plasmid, and tested in luciferase reporter assays. Both YAP and TAZ
strongly activated the IL6 promoter-luciferase activity (Fig 3E). Chromatin immunoprecipita-
tion (ChIP) assays demonstrated direct binding of YAP and TAZ to IL6 promoter (Fig 3F).
Mutation of TBS sites within the IL6 promoter fragments significantly reduced YAP’s ability
to activate these promoter fragments in the luciferase reporter assays (Fig 3G). To further dem-
onstrate that Tead binding is necessary for YAP-mediated activation of IL6 promoter, Hippo
signaling inhibitor VP, was added 24 hours after transfection. Activation of IL6 promoter by
YAP or TAZ was completely abolished by VP (Fig 3H). We next performed luciferase assay
using IL6 reporter co-transfected with YAP plasmid in the presence or absence of VP or
MAPK inhibitor SB203580 (S8B and S8C Fig). We observed a mild reduction in the luciferase
activity in the presence of SB203580. In contrast, VP completely blocked the YAP-medicated
IL6 activation suggesting that direct regulation of IL6 by YAP may play a dominant role com-
pared to the MAPK pathway in mediating IL6 activation (S8B and S8C Fig). Together, these
results demonstrate that YAP/TAZ promote pro-inflammatory macrophage phenotype by
modulating IL6 production.
YAP/TAZ deficiency promotes reparative macrophage phenotype
To characterize the reparative macrophage phenotype in YAP/TAZ-dKO, we isolated BMDMs
from control and YAP/TAZ-dKO mice and treated them with/without IL4/IL13 for 12 hours.
Total RNA was isolated for qPCR analysis. In both unstimulated and stimulated conditions,
YAP/TAZ-dKO BMDMs exhibited increased levels of reparative genes such as Arg1, Egr2,
Fig 2. Macrophage-specific gene expression changes due to YAP/TAZ deletion. (A) Venn analysis of RNA-seq data showing overlap between significantly
differentially expressed genes (false discovery rate [FDR]� 5%, absolute log2FC�1.0) between control and YAP/TAZ-dKO BMDMs with and without LPS/IFNγ
treatment. (B) Heat map of 45 differentially expressed genes (out of a total of 86 genes) identified by Venn analysis of RNA-seq data. (C) Pathway enrichment analysis
of the RNA-seq data from untreated or LPS/IFNγ treated control and YAP/TAZ-dKO BMDMs. (D) MA plots for selected pathways showing top differentially
expressed pathway genes. MA plots for pro-inflammatory macrophage marker genes are also presented. (E) BMDMs were isolated from control and YAP/TAZ-dKO
mice and stimulated with/without LPS/IFNγ for 12 hours. (A) qRT-PCR for pro-inflammatory marker genes, IL6, IL1β, IL12β, Nos2, TNFα, Ccl2, and Rantes using
RNA isolated from untreated or LPS/IFNγ-treated control and YAP/TAZ-dKO BMDMs. n = 3 in each group. (F) NO production determined by nitrite (NO2−) levels
in conditioned medium prepared from untreated or LPS/IFNγ-treated control and YAP/TAZ-dKO BMDMs. n = 3 in each group. For numerical raw data, please see
S1 Data. BMDMs, bone marrow–derived macrophages; Ccl2, C–C motif chemokine ligand 2; FDR, false discovery rate; IFNγ, interferon gamma; IL, interleukin; LPS,
lipopolysaccharide; NO, nitric oxide; Nos2, nitric oxide synthase 2; qRT-PCR, real-time quantitative reverse transcription PCR; RNA-seq, RNA sequencing; TAZ,
transcriptional coactivator with PDZ-binding motif; TNFα, tumor necrosis factor alpha; UNT, untreated; YAP, yes-associated protein; YAP/TAZ-dKO, YAP/TAZ
double knockout.
https://doi.org/10.1371/journal.pbio.3000941.g002
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Cd206, Ym1, and fibronectin 1 (Fn1) (Fig 4A). Given that reparative (M2) macrophages can be
subdivided into 3 categories—namely, M2a, M2b, and M2c. We, therefore, stimulated control
and YAP/TAZ-dKO BMDMs with respective stimuli and analyzed the marker gene expres-
sions for all 3 reparative subcategories. Consistently, the expression of reparative subset genes
was also increased in YAP/TAZ-dKO BMDMs. For example, the expression of marker genes
for M2a (Cd206 and Ym1), M2b (Il10 and Il1ra), and M2c (matrix metallopeptidase 9
(Mmp9)) was increased in YAP/TAZ-dKO BMDMs (S9A–S9C Fig). Alternatively, a decrease
in the expression of the M2c marker gene Tgfβ was observed in YAP/TAZ-dKO BMDMs com-
pared to control under M2c-stimulated conditions (S9C Fig). Gene expression data were fur-
ther supported by western blot analysis for Arg1, showing increased protein expression in
YAP/TAZ-dKO BMDMs (Fig 4B). Activated PI3K/AKT pathway has also been recognized as
an essential step toward reparative macrophage polarization as its inhibition abrogates the up-
regulation of reparative genes [48]. We, therefore, analyzed the levels of phosphorylated AKT
in control and YAP/TAZ-dKO BMDMs treated with IL4/IL13. We observed a significant
increase in phosphorylated AKT level in YAP/TAZ-deficient macrophages after 30 minutes of
IL4/IL13 treatment suggesting that YAP/TAZ deficiency promotes reparative phenotype (Fig
4C). A recent study has demonstrated that p53 is expressed in both pro-inflammatory and
reparative macrophages and regulates reparative phenotype [49]. Surprisingly, our RNA-seq
analysis did not detect any change in tumor protein 53 (Trp53) expression during pro-inflam-
matory macrophage polarization (S10A Fig). Similarly, p53 levels were not altered during
reparative macrophage polarization in YAP/TAZ-deficient BMDMs suggesting that YAP/
TAZ-mediated macrophage polarization is not dependent on p53 (S10B Fig).
Next, to further examine how YAP/TAZ are involved in reparative macrophage polariza-
tion, we treated RAW264.7 cells, PMs, and BMDMs with IL4/IL13 for 0 to 24 hours and per-
formed YAP, pYAP, and TAZ western blot analysis. We observed increased expression of YAP
after 6 to 8 hours of stimulation and remained steady for 12 to 24 hours, in all tested cell types
(Fig 4D–4F). Similarly, the phosphorylated level of YAP was also elevated. Similar to YAP, the
expression of TAZ was also enhanced in all 3 macrophage cells upon IL4/IL13 treatment (Fig
4D–4F). Moreover, since YAP/TAZ exert their functions in the nucleus, we furthermore mea-
sured the nuclear abundance of YAP/TAZ together with cytoplasmic expression of pYAP in
BMDMs after IL4/IL13 treatment for 8 and 12 hours. Western blot analysis revealed a signifi-
cant increase of YAP, TAZ, and pYAP protein levels upon IL4/IL13 treatment (S1 Fig).
Fig 3. YAP/TAZ deficiency impairs pro-inflammatory macrophage phenotype. (A) BMDMs were isolated from control and YAP/
TAZ-dKO mice and stimulated with/without LPS/IFNγ for 12 hours. Western blot analysis for IL6, IL1β, and Nos2 was performed
using total lysates from untreated or LPS/IFNγ-treated control and YAP/TAZ-dKO BMDMs. β-actin is shown as a loading control.
The relative protein expression was quantified. (B) BMDMs were isolated from control and YAP/TAZ-dKO mice and stimulated with/
without LPS/IFNγ for 15 and 30 minutes. The phosphorylated level of JNK, p38, Erk1/2, IKKαβ, and Tak1 was detected by western
blot analysis, and the relative expression was quantified. β-actin is shown as a loading control. (C) Reported TBSs. (D) Predicted TBSs
in IL6 promoter. IL6-promoter fragments I (Pro-I) and III (Pro-III) harbor 3 TBSs, while fragment II (Pro-II) harbors 4 TBSs. (E)
Results of normalized luciferase reporter assays in HEK293T cells with full-length IL6-luciferase reporter (approximately 2Kb
promoter) in the presence of YAP or TAZ. (F) ChIP assay using chromatin from wild-type untreated or LPS/IFNγ treated BMDMs
with IgG, YAP, and TAZ antibody. (G) IL6-promoter fragments (Pro-I, Pro-II, and Pro-III) containing wild-type TBSs driving
luciferase were compared to mutant fragments with mutated TBSs. (H) IL6 and Tead-luciferase reporters were transfected in
HEK293T cells with/without YAP or TAZ in the presence or absence of verteporfin (5 μM). Data from luciferase experiments are
presented as mean ± SD. For numerical raw data, please see S1 Data. BMDMs, bone marrow–derived macrophages; ChIP, chromatin
immunoprecipitation; Erk1/2, extracellular signal-regulated kinase 1/2; HEK293T, human embryonic kidney 293 T; IFNγ, interferon
gamma; IgG, immunoglobulin G; IKKαβ, inhibitor of nuclear factor kappa-αβ-kinase; IL, interleukin; JNK, c-Jun N-terminal kinase;
LPS, lipopolysaccharide; Nos2, nitric oxide synthase 2; SD, standard deviation; Tak1, transforming growth factor beta-activated kinase
1; TAZ, transcriptional coactivator with PDZ-binding motif; TBSs, Tead-binding sequences; Tead, Transcriptional enhanced associate
domain; VP, verteporfin; YAP, yes-associated protein; YAP/TAZ-dKO, YAP/TAZ double knockout.
https://doi.org/10.1371/journal.pbio.3000941.g003
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To determine how YAP/TAZ inhibit Arg1 expression, we analyzed the promoter of Arg1
and identified 10 consensus TBSs within the 3.1Kb promoter fragment and first exon (S11
Fig). We then tested the Arg1 promoter fragment in luciferase reporter assays. Both YAP and
TAZ strongly inhibited the Arg1 promoter-luciferase activity in a dose-dependent manner
(Fig 4G). ChIP assays demonstrated direct binding of YAP to the Arg1 promoter (Fig 4H). To
determine the molecular mechanism of YAP/TAZ-mediated transcriptional repression fur-
ther, we tested the hypothesis that YAP/TAZ interact with HDAC3-NCoR1 complex to repress
Arg1 expression in macrophages. We observed that Arg1 promoter-luciferase activity was fur-
ther repressed when both YAP and HDAC3 were co-expressed compared to YAP alone (Fig
4I). A similar repressive response to Arg1 promoter-luciferase activity was obtained when TAZ
was co-expressed together with HDAC3 (Fig 4J). The repressive response to Arg1 promoter-
luciferase activity was further enhanced when HDAC3 was co-expressed together with
YAPS127A (a constitutively active form that remains in the nucleus and is transcriptionally
active) compared to YAP (Fig 4K).
To determine whether YAP physically interacts with HDAC3-NCoR1 repressor complexes,
we co-transfected RAW264.7 cells with plasmid constructs expressing YAP-Myc and
HDAC3-FLAG, followed by immunoprecipitation using either FLAG-tag or Myc-tag followed
by western blot for Myc and FLAG respectively. We found that YAP interacted with HDAC3
in RAW264.7 cells (Fig 4L). We extended these studies further and treated wild-type BMDMs
with IL4/IL13 and performed immunoprecipitation experiments using antibody against YAP
and western blot for HDAC3 and NCoR1. We detected both HDAC3 and NCoR1 protein in
the YAP immunoprecipitated samples compared to immunoglobulin G (IgG) controls sug-
gesting an interaction between YAP, HDAC3, and NCoR1 (Fig 4M). To determine if HDAC3
exerts its repressive function exclusively by interacting with YAP/TAZ on Arg1 promoter, we
performed a knockdown experiment using HDAC3 siRNA followed by IL4/IL13 treatment on
BMDMs from control and YAP/TAZ-dKO mice. The knockdown efficiency ofHDAC3 in
BMDMs was confirmed by western blot analysis (Fig 4N). In control BMDMs, HDAC3
Fig 4. YAP interacts with the HDAC3-NCoR1 repressor complex to inhibit reparative macrophage phenotype. (A) BMDMs were isolated
from control and YAP/TAZ-dKO mice and stimulated with/without IL4/IL13 for 12 hours. qRT-PCR for reparative marker genes, Arg1, Egr2,
Cd206, Ym1, Fizz1, and Fn1 using RNA isolated from untreated or IL4/IL13-treated control and YAP/TAZ-dKO BMDMs. n = 3 in each group.
Gene expression results were normalized to gapdh, and results are represented as fold change. (B) Western blot analysis for Arg1 was performed
using total lysates from untreated or IL4/IL13-treated control and YAP/TAZ-dKO BMDMs. β-actin is shown as a loading control. The relative
protein expression was quantified. (C) BMDMs were isolated from control and YAP/TAZ-dKO mice and stimulated with/without IL4/IL13 for
15 and 30 minutes. The phosphorylated level of AKT was detected by WB analysis, and the relative protein expression was quantified. Vinculin
is shown as a loading control. (D–F) WB analysis for YAP, pYAP (S127), and TAZ was performed using total lysates from RAW264.7 cells,
wild-type PMs, and BMDMs treated with IL4/IL13 for 0 to 24 hours as indicated. β-actin, GAPDH, or vinculin are shown as a loading control.
The relative protein expression was quantified. (G) Results of normalized luciferase reporter assays in HEK293T cells with Arg1-luciferase
reporter in the presence of YAP or TAZ. (H) ChIP assay using chromatin from wild-type IL4/IL13 treated BMDMs with IgG or YAP antibody.
(I–K) Results of normalized luciferase reporter assays in HEK293T cells with Arg1-luciferase reporter in the presence of YAP, TAZ, YAPS127A,
and HDAC3 alone or as indicated combinations. (L) RAW264.7 cells were co-transfected with YAP-Myc and HDAC3-FLAG plasmids for 48
hours and then treated with IL4/IL13 for 12 hours. IP was performed using IgG control, anti-FLAG, and anti-Myc antibodies followed by WB
for the Myc or FLAG tag. (M) Wild-type BMDMs were treated with IL4/IL13 for 12 hours, and IP was performed using IgG or an anti-YAP
antibody followed by WB for YAP, HDAC3, and NCoR1. (N) BMDMs were isolated from control and YAP/TAZ-dKO mice and transfected
with control, YAP, or HDAC3 siRNA for 72 hours, followed by IL4/IL13 stimulation for 16 hours. RNA was prepared for qRT-PCR analysis of
Arg1. (O–Q) Results of normalized luciferase reporter assays in HEK293T cells with Arg1-luciferase reporter when YAP, HDAC3 alone, or their
combinations were transfected in the presence or absence of vorinostat, scriptaid, or RGFP966. (R) Results of normalized luciferase reporter
assays in HEK293T cells transfected with Arg1-luciferase reporter with or without YAP. After 24 hours, cells were infected with either HDAC3
or HDAC3H134A, H135A lentivirus and analyzed 48 hours after infection. Data from luciferase experiments are presented as mean ± SD. For
numerical raw data, please see S1 Data. Arg1, Arginase-I; BMDMs, bone marrow–derived macrophages; Cd206, cluster of differentiation 206;
Egr2, early growth response 2; Fizz1, found in inflammatory zone 1; Fn1, fibronectin 1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
HDAC3, histone deacetylase 3; HEK293T, human embryonic kidney 293 T; IgG, immunoglobulin G; IL, interleukin; IP, immunoprecipitation;
NCoR1, nuclear receptor corepressor 1; NS, non-significant; PMs, peritoneal macrophages; pYAP, phosphorylated YAP; qRT-PCR, real-time
quantitative reverse transcription PCR; siRNA, short interfering RNA; WB, western blot; YAP, yes-associated protein; YAP/TAZ-dKO, YAP/
TAZ double knockout.
https://doi.org/10.1371/journal.pbio.3000941.g004
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knockdown resulted in the up-regulation of Arg1 expression (approximately 5-fold) compared
to control siRNA. In YAP/TAZ-dKO BMDMs, Arg1 expression was elevated; however,
the knocking down ofHDAC3 further increased (approximately 2-fold) the Arg1 expression
suggesting that HDAC3 can also modulate Arg1 expression by alternative mechanisms
(Fig 4N).
To further understand the structural versus enzymatic (deacetylase activity) role of HDAC3
in the repression of Arg1, we utilized pan-HDAC inhibitor vorinostat and scriptaid as well as
HDAC3-specific inhibitor RGFP966. First, we co-transfected the HEK293T cells with both
YAP and HDAC3 constructs in the presence or absence of vorinostat or scriptaid. We
observed that both vorinostat or scriptaid treatment abolished the YAP-HDAC3 mediated
repression of Arg1 (Fig 4O and 4P). This was not surprising, as both vorinostat and scriptaid
are known to affect both protein expression as well as the deacetylase activity of HDACs
including HDAC3 [50–52]. To further support our findings that the enzymatic function of
HDAC3 is not essential for HDAC3-mediated repression of Arg1, we utilized RGFP966, an
HDAC3-specific inhibitor. In multiple biological systems, RGFP966 has been shown to affect
the deacetylase activity but not the protein expression of HDAC3 [53,54]. We observed that
RGFP966 treatment did not affect the YAP-HDAC3 mediated repression of Arg1 (Fig 4Q). To
further demonstrate that the deacetylase activity of HDAC3 is not required for Arg1 repres-
sion, we utilized a previously described mutant form of HDAC3 in which 2 highly conserved
tandem His residues, 134 and 135, are mutated to alanine (HDAC3H134A, H135A). These muta-
tions do not affect its expression, chromatin recruitment, and interaction with NCOR1; how-
ever, they make HDAC3 completely enzymatically inactive [55,56]. We observed that
HDAC3H134A, H135A mutant was able to repress the Arg1 reporter similar to HDAC3 suggest-
ing that the deacetylase activity of HDAC3 is not required for Arg1 repression (Fig 4R).
YAP/TAZ negatively regulates the bactericidal activity of macrophages
Since YAP/TAZ-deficient macrophages display reduced pro-inflammatory phenotype, we
hypothesized that they may have reduced bactericidal activity. We performed the bacterial kill-
ing assay, in which BMDMs from control and YAP/TAZ-dKO mice were infected with either
gram-negative (Escherichia coli) or gram-positive (Listeria monocytogenes) bacteria for 2
hours. The BMDMs were then thoroughly washed and incubated for 16 hours (S12A Fig).
YAP/TAZ-deficient macrophages showed significantly decreased bactericidal activity toward
both gram-negative (S12B and S12C Fig) and gram-positive bacteria (S12F and S12G Fig), as
evident by increased bacterial colony formation. To examine the molecular basis of bacterial
killing, we also measured the levels of NO production and consequently performed pro-
inflammatory marker gene expression analysis. We found that both NO and expression of IL6,
IL1β, IL12, Rantes, and Nos2 were significantly down-regulated in YAP/TAZ-deficient macro-
phages when infected with both gram-negative and gram-positive bacteria (S12D, S12E, S12H
and S12I Fig). We did not observe any significant alterations in NO and pro-inflammatory
gene expression at the basal level. However, we observed that Rantes and Nos2 expressions
were decreased in YAP/TAZ-dKO macrophages after L.monocytogenes infection (S12D, S12E,
S12H and S12I Fig). To further investigate the effect of YAP activation on bacterial killing effi-
ciency, we isolated BMDMs from control and LysMCre; R26YAP5SAmice and performed similar
bacterial killing experiments described above. BMDMs isolated from LysMCre; R26YAP5SAmice
displayed a significantly greater bactericidal activity toward both gram-negative and gram-pos-
itive bacteria. Increased bactericidal activity in LysMCre; R26YAP5SA BMDMs was associated
with increased production of NO, as well as higher expression of pro-inflammatory genes such
as IL6, IL1β, Rantes, and Nos2 (S13 Fig).
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YAP/TAZ-deficient mice show improved cardiac function recovery post-MI
Macrophage polarization is a common event after MI, where macrophage phenotypes control
the degree of cardiac damage, repair, and function [6,14]. We, therefore, investigated whether
YAP/TAZ deficiency affects macrophage polarization and cardiac function after MI. We initially
examined the cardiac function in YAP/TAZ-dKO and control mice at baseline and 4-week post-
MI using echocardiographic (echo) analysis. Under baseline conditions, YAP/TAZ-dKO hearts
show normal left ventricular ejection fraction (LVEF), fractional shortening (FS), left ventricular
end-systolic volume (LVESV), left ventricular end-diastolic volume (LVEDV), stroke volume
(SV), fractional area change (FAC), and left ventricular mass (LV Mass) similar to their litter-
mate controls (Fig 5A–5E and S14 Fig). However, LVEF in control is severely reduced from an
average of 66.34% to 24.94% (62.4% reduction compared to baseline) post-MI. In contrast, we
observed significantly preserved LVEF in YAP/TAZ-dKO, from 60.24% at baseline to 42.17%
post-MI (29.99% reduction compared to baseline) (Fig 5A). FS was not affected at baseline in
both control and YAP/TAZ-dKO mice. However, post-MI, FS is significantly preserved in YAP/
TAZ-dKO (from 16.63% at baseline to 9.93% post-MI; 40.28% reduction compared to baseline)
compared with controls (from 17.84% at baseline to 5.83% post-MI; 67.32% reduction com-
pared with baseline) (Fig 5B). LVESV was not affected at baseline in both control and YAP/
TAZ-dKO mice. However, post-MI, LVESV is significantly reduced in YAP/TAZ-dKO (from
14.93 μL at baseline to 52 μL post-MI; 3.48 fold more blood retention compared to baseline)
compared with controls (from 12.79 μL at baseline to 78.84 μL post-MI; 6.16 fold more blood
retention compared to baseline) (Fig 5C). FAC in control is severely reduced from an average of
48.65% to 16.41% (66.26% reduction compared to baseline) post-MI. In contrast, we observed
significantly preserved FAC in YAP/TAZ-dKO, from 42.83% at baseline to 25.49% post-MI
(40.48% reduction compared to baseline) (Fig 5D). In addition, the SV was also improved from
24.73% in controls to 34.81% (40.47% increase) in YAP/TAZ-dKO mice compared to controls
after MI. No significant change in the LVEDV and LV mass was observed (S14 Fig).
Next, we investigated whether protected cardiac function in YAP/TAZ-deficient mice after
MI is due to changes in macrophage subpopulation and pro-inflammatory and reparative gene
expression. We quantified the macrophage numbers by flow cytometry and examined the
expression of pro-inflammatory and reparative genes from isolated macrophages from control
and YAP/TAZ-dKO mice after MI. At day 2 post-MI, the number of pro-inflammatory macro-
phages (F4/80+iNOS+) was significantly reduced in YAP/TAZ-deficient hearts compared with
control hearts (Fig 5F, S5C Fig, S20 Fig and S1–S9 FCS files). However, at day 6 post-MI, the
percentage of reparative macrophages (F4/80+CD206+) was increased in YAP/TAZ-deficient
hearts relative to controls (Fig 5F, S5D Fig, S21 Fig and S10–S22 FCS files). The expression
profiling for pro-inflammatory and reparative genes reflected the similar results in fluores-
cence-activated cell sorting (FACS)-sorted macrophages, where levels of pro-inflammatory
gene such as IL6, IL1β, and Nos2 were reduced, while expressions of reparative genes such as
Arg1, Ym1, and Fizz1 were elevated in YAP/TAZ-deficient mice (Fig 5G and 5H). We also per-
formed pro-inflammatory and reparative gene expression analysis on heart tissues (LV) iso-
lated from control and YAP/TAZ-dKO mice after 3 and 7 days post-MI. We observed reduced
expression of pro-inflammatory genes such as IL6, IL1β, TNFα, Nos2, Ccl2, Rantes, and Ccr7
in YAP/TAZ-dKO hearts compared with controls during early inflammatory phase at day 3
post-MI, indicating impaired pro-inflammatory function (Fig 5I). In contrast, we detected
increased expression of reparative genes such as Arg1, Ym1, and Egr2 and decreased levels of
pro-fibrotic genes such as IL10 and TGFβ1 in YAP/TAZ-dKO hearts when compared with
controls during early reparative phage at day 7 post-MI. No significant change was detected in
the expression of other reparative genes such as Fizz1 and Cd206 (Fig 5J).
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Recruitment of neutrophils to the infarcted area is 1 of the earliest events after MI; we,
therefore, investigated whether myeloid-specific YAP/TAZ deficiency affects the neutrophil
recruitment/accumulation to the injured myocardium. At day 2 post-MI, the number of mye-
loperoxidase positive cells (MPO+), a well-known neutrophil marker, was not alternated in
YAP/TAZ-deficient hearts compared with control hearts (S15A Fig). Similarly, in vitro neutro-
phil migration was also not affected due to YAP/TAZ deletion (S15B Fig).
MI injury leads to hypoxia and oxidative stress, which ultimately induces reactive oxygen
species production that accelerates the progression of ischemic heart disease.
To identify the factors affecting YAP/TAZ expression in the post-MI heart, we tested the
hypothesis that hypoxia may cause up-regulation of YAP/TAZ in macrophages. We treated
BMDMs with H2O2 to mimic hypoxic condition and performed western blot analysis. The
protein expression of YAP, TAZ, and Nos2 was significantly elevated after H2O2 treatment
demonstrating that ischemic condition can stimulate YAP/TAZ expression in macrophage
(S16 Fig).
Improved post-MI ventricular remodeling and angiogenesis in YAP/TAZ-
deficient hearts
YAP/TAZ-deficient hearts exhibited decreased pro-inflammatory and increased reparative
response following MI. To determine the impact of these changes on cardiac tissue repair, we
first quantified the initial ischemic area in both control and YAP/TAZ-dKO hearts at days 2
post-MI. No significant change was observed between the 2 groups (S17A Fig). Next, we
sought to study the impact of these changes on cardiac tissue repair processes such as fibrosis,
hypertrophy, and angiogenesis at days 2, 7, and 28 post-MI. Masson’s trichrome staining
showed no alteration in fibrosis at day 2 post-MI in YAP/TAZ-dKO hearts compared to con-
trol (S17B Fig); however, a significantly reduced fibrotic area was detected in YAP/TAZ-dKO
hearts compared with controls at day 28 post-MI (Fig 6A and 6B). Additionally, interstitial
myocardial fibrosis was also attenuated in YAP/TAZ-dKO heart at day 28 post-MI compared
to controls (S18A and S18B Fig). Consistent with reduced fibrosis, expression of collagen (type
I), the most abundant isoform found in fibrotic tissue, was significantly reduced in YAP/TAZ-
dKO hearts compared with controls (Fig 6C and 6D). We then examined the mRNA level of
genes involved in pro-fibrotic events. We observed reduced expression of genes required for
myofibroblasts formation (smooth muscle actin alpha 2 (Acta2) and transgelin (Tagln)), colla-
gen biosynthesis (collagen type I α 1 (Col1α1), prolyl 4-hydroxylase subunit alpha-1 (P4ha1),
Fig 5. Improved recovery of cardiac function in YAP/TAZ-deficient mice post-MI. (A–E) Echocardiographic measurements of ventricular
functional parameters at baseline and 4-week post-MI from control and YAP/TAZ-dKO mice: (A) LVEF; (B) FS; (C) LVESV; (D) FAC; (E)
Representative echocardiographic M-mode images of LV. Data are shown as mean ± SEM (n = 4 to 7 per group). (F–H) Flow cytometry
analysis of pro-inflammatory (iNOS+/F4/80+) and reparative (CD206+/F4/80+) macrophages from the 2 and 6 days post-MI hearts: (F)
percentage of pro-inflammatory (F4/80+iNOS+) and reparative (F4/80+CD206+) macrophages. Underlying raw data can be found in S1 Data
and S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21 and S22 FCS files. (G) qRT-PCR for pro-
inflammatory cytokines IL6, IL1β, and Nos2 in isolated iNOS+/F4/80+ macrophages from the 2 days post-MI hearts. (H) qRT-PCR for anti-
inflammatory markers Arg1, Ym1, and Fizz1 in isolated CD206+/F4/80+ macrophages from the 6 days post-MI hearts. (I) qRT-PCR for pro-
inflammatory marker genes, IL6, IL1β, TNFα,Nos2, Ccl2, Ccr7, and Rantes using RNA isolated from control and YAP/TAZ-dKO hearts (LV) at
3 days post-MI. n = 4 in each group. (J) qRT-PCR for anti-inflammatory marker genes, Ym1, Egr2, Arg1, Fizz1, Cd206, IL10, and TGFβ using
RNA isolated from control and YAP/TAZ-dKO hearts (LV) at 7 days post-MI. n = 3 to 4 in each group. Gene expression results were
normalized to Gapdh, and results are represented as fold change. For numerical raw data, please see S1 Data. Arg1, Arginase-I; Ccl2, C–C motif
chemokine ligand 2; Ccr7, C-C chemokine receptor type 7; Cd206, cluster of differentiation 206; Egr2, early growth response 2; FAC, fractional
area change; Fizz1, found in inflammatory zone 1; FS, fractional shortening; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; IL,
interleukin; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; MI, myocardial infarction; Nos2, nitric oxide
synthase 2; NS, non-significant; qRT-PCR, real-time quantitative reverse transcription PCR; TAZ, transcriptional coactivator with PDZ-
binding motif; TGFβ, transforming growth factor beta; TNFα, tumor necrosis factor alpha; YAP, yes-associated protein; YAP/TAZ-dKO, YAP/
TAZ double knockout.
https://doi.org/10.1371/journal.pbio.3000941.g005
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procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (Plod2), Plod2b, and lysyl oxidase (Lox))
and remodeling (tissue inhibitor matrix metalloproteinase 1 (Timp1) in YAP/TAZ-deficient
hearts compared with controls at both days 7 and 28 post-MI (Fig 6E). Interestingly, the
expression of Col1α2, Axin2, and Timp1 was decreased in YAP/TAZ-dKO hearts only on day
7, but not at day 28 post-MI. Furthermore, to understand whether YAP/TAZ deficiency affects
cardiac hypertrophy, we measured cardiomyocyte cross-sectional area and determined the
expression of fetal genes. We found a reduced cardiomyocyte size in both border and remote
zone of YAP/TAZ-dKO infarcted heart compared to controls as evident by wheat germ agglu-
tinin (WGA) staining at 4 weeks post-MI (S18C and S18D Fig). Further supporting evidence
showed a decrease in hypertrophy gene levels of myosin heavy chain 7 (Myh7), natriuretic pep-
tide A (Nppa), and natriuretic peptide B (Nppb) in YAP/TAZ-dKO infarcted heart, suggesting
an improvement in cardiac hypertrophy after MI (S18E Fig). These data suggest that both pro-
inflammatory and reparative macrophage phenotypes after MI are YAP/TAZ dependent. Spe-
cifically, YAP/TAZ deficiency reduces macrophage-mediated pro-inflammatory response and
adverse remodeling to preserve the cardiac function after MI.
To understand the mechanism of the vascular repair process after MI, we examined
whether the expression level of angiogenic factors was affected in YAP/TAZ-deficient hearts.
We observed significantly increased expression of Vegf and vascular cell adhesion molecule 1
(Vcam1) in YAP/TAZ-dKO hearts at day 7 post-MI (Fig 6F). We also observed a similar
increasing trend at day 28 post-MI. However, the differences were not statistically significant.
To further explore the process of neovascularization, we performed endomucin (Emcn) and
CD31 immunohistochemistry on control and YAP/TAZ-dKO hearts at day 28 post-MI. Com-
pared with control, we observed increased expression of Emcn and CD31, markers for endo-
thelial cells of the capillary network, in the border zone of the infarcted myocardium of YAP/
TAZ-dKO mice (Fig 6G and S19A Fig). Consistently, capillary density was also significantly
increased in YAP/TAZ-dKO infarcted hearts compared with controls as evidenced by lectin
staining (S19B Fig). Collectively, these results demonstrate that YAP/TAZ deficiency leads to
improved vascularization of the infarcted myocardium. This may subsequently contribute to
improved cardiac function recovery observed in YAP/TAZ-dKO mice.
YAP activation promotes pro-inflammatory and inhibits reparative
macrophage phenotype
To further establish the role of YAP in macrophage polarization, we activated YAP in myeloid
cells using a conditional Rosa26 allele, R26YAP5SA, and LysMCremice. This allele enables the in
vivo expression of a constitutively active form of YAP (Fig 7A). YAP5SA contains 5 canonical
large tumor suppressor kinase (Lats) phosphorylation sites mutated from serine to alanine that
Fig 6. Improved post-MI ventricular remodeling and angiogenesis in YAP/TAZ-deficient hearts. (A) Masson’s trichrome staining on control and
YAP/TAZ-dKO hearts at 28 days post-MI. (B) Quantification of Masson’s trichrome stained fibrotic area in control and YAP/TAZ-dKO hearts at 28
days post-MI (n = 6 to 7 per group). Fibrotic area was normalized to the remaining heart for each heart section. (C) Immunostaining showing the
expression of collagen type I in infarct zone on control and YAP/TAZ-dKO heart sections at 28 days post-MI. DAPI was used to stain nuclei. Scale bar
100 μM. (D) Quantification of collagen type I positive area in control and YAP/TAZ-dKO heart sections. n = 3 per group. (E) qRT-PCR for profibrotic
genes involved in collagen biosynthesis using RNA isolated from control and YAP/TAZ-dKO hearts (LV) at 7 and 28 days post-MI. n = 3 to 4 in each
group. (F) qRT-PCR for angiogenic factors Vegf and Vcam1 using RNA isolated from control and YAP/TAZ-dKO hearts (LV) at 7 and 28 days post-MI.
n = 3 to 4 in each group. (G) Immunohistochemistry and quantification for Emcn on control and YAP/TAZ-dKO heart sections. For numerical raw
data, please see S1 Data. Scale bar 100μM. Acta2, smooth muscle actin alpha 2; Col1α1, collagen type I α 1; Col1α2, collagen type I α 2; Emcn,
endomucin; Epi, epicardium; Lox, lysyl oxidase; LV, left ventricular; MI, myocardial infarction; Myo, myocardium; NS, non-significant; p4ha1, prolyl
4-hydroxylase subunit alpha-1; plod2, procollagen-lysine,2-oxoglutarate 5-dioxygenase 2; Plod2b, procollagen-lysine,2-oxoglutarate 5-dioxygenase 2b;
qRT-PCR, real-time quantitative reverse transcription PCR; Tagln, transgelin; TAZ, transcriptional coactivator with PDZ-binding motif; Timp1, tissue
inhibitor matrix metalloproteinase 1; Vcam1, vascular cell adhesion molecule 1; Vegf, vascular endothelial growth factor; YAP, yes-associated protein;
YAP/TAZ-dKO, YAP/TAZ double knockout.
https://doi.org/10.1371/journal.pbio.3000941.g006
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halt Hippo/Lats-mediated degradation of YAP [57]. R26YAP5SA and LysMCre;R26YAP5SAmice
are referred to as control and LysMCre;R26YAP5SA, respectively. YAP overexpression was con-
firmed by western blot analysis (Fig 7B). In addition to YAP5SA, the R26YAP5SA allele also car-
ries a carboxyl-terminal internal ribosome entry site (IRES)-nuclear LacZ tag. The expression
of the R26YAP5SA transgene in BMDMs was further confirmed by β-gal and CD68 double
immunostaining. Nuclear β-gal staining is observed in CD68 positive macrophages (Fig 7C).
To determine the molecular changes associated with YAP activation, we isolated BMDMs
from control and LysMCre;R26YAP5SAmice and treated them with/without LPS/IFNγ or IL4/
IL13. In unstimulated conditions, no significant changes in the expression of pro-inflamma-
tory and reparative macrophage marker genes were detected between control and LysMCre;
R26YAP5SA BMDMs (Fig 7D–7F). However, upon LPS/IFNγ treatment, LysMCre;R26YAP5SA
BMDMs displayed a significant increase in pro-inflammatory gene expressions (IL6, IL1β,
IL12β, Nos2, TNFα, Ccl2, Rantes, and Ccr7) as compared with control BMDMs (Fig 7D). Also,
increased NO levels were detected in the condition media isolated from LysMCre;R26YAP5SA
BMDMs treated with LPS/IFNγ (Fig 7E). However, IL4/IL13 treated LysMCre;R26YAP5SA
BMDMs exhibited a decrease in the expression of reparative genes (Arg1, Ym1, and Cd206)
when compared with control BMDMs (Fig 7F). Together, these data demonstrate that YAP
activation can stimulate pro-inflammatory and inhibit reparative macrophage phenotype.
Next, we investigated whether gene expression changes observed due to YAP activation in
macrophages has any impact on cardiac fibrosis following MI. Masson’s trichrome staining
showed increased fibrotic area in LysMCre;Rosa26YAP5SA hearts compared with controls at 28
days post-MI (Fig 7G and 7H). Similar to increased fibrosis, expression of collagen type I was
also more pronounced in LysMCre;Rosa26YAP5SA hearts compared to controls (Fig 7I and 7J)
suggesting that cardiac remodeling is adversely affected leading to more fibrotic tissues and
excess accumulation of extracellular matrix after MI.
Discussion
Macrophages are present virtually in every tissue of the body, either as a resident or monocyte-
derived cells. They infiltrate into tissues and provide immunity against pathogens, tissue devel-
opment, homeostasis, and repair following damage. The robust inflammatory response after
MI is essential for cardiac repair. However, timely suppression and containment of inflamma-
tion are also required for efficient and proper cardiac repair. Experimental studies have dem-
onstrated that overactive or prolonged inflammatory response could lead to cardiomyocytes
death, impaired systolic function, fibrosis, left ventricular dilatation, and heart failure
Fig 7. YAP activation enhances pro-inflammatory but inhibits reparative macrophage phenotype. (A) Generation of transgenic mice expressing YAP5SA, a
constitutively active form of YAP in macrophages by crossing Rosa26YAP5SAmice with LysMCremice. (B) Western blot analysis for YAP was performed using total
lysates from control and LysMCre;Rosa26YAP5SA BMDMs. β-actin is shown as a loading control. (C) Double immunofluorescence for β-galactosidase (red) and CD68
(green) was performed on control and LysMCre;Rosa26YAP5SA BMDMs. Nuclei were visualized by DAPI staining (blue). Scale bar 50 μM. (D–F) BMDMs were isolated
from control and LysMCre;Rosa26YAP5SAmice and stimulated with/without LPS/IFNγ or IL4/IL13 for 24 hours. (D) qRT-PCR for pro-inflammatory marker genes, IL6,
IL1β, IL12β, Nos2, TNFα, Ccl2, Rantes, and Ccr7 using RNA isolated from untreated or LPS/IFNγ-treated control and LysMCre;Rosa26YAP5SA BMDMs. n = 3 in each
group. (E) NO production determined by nitrite (NO2−) levels in conditioned medium prepared from untreated or LPS/IFNγ-treated control and LysMCre;
Rosa26YAP5SA BMDMs. n = 3 in each group. (F) qRT-PCR for reparative marker genes, Arg1, Ym1, Cd206, and Fizz1 using RNA isolated from untreated or IL4/
IL13-treated control and LysMCre;Rosa26YAP5SA BMDMs. n = 3 in each group. Gene expression results were normalized to gapdh, and results are represented as fold
change. (G) Masson’s trichrome staining on control and LysMCre;Rosa26YAP5SA hearts at 28 days post-MI. Fibrotic area was normalized to the remaining heart for each
heart section. (H) Quantification of Masson’s trichrome stained fibrotic area in control and LysMCre;Rosa26YAP5SA hearts at 28 days post-MI (n = 4 per group). (I)
Immunostaining showing the expression collagen type I in infarct zone on control and LysMCre;Rosa26YAP5SA heart sections at 28 days post-MI. DAPI was used to stain
nuclei. Scale bar 100 μM. (J) Quantification of collagen type I positive area in control and LysMCre;Rosa26YAP5SA heart sections. n = 3 per group. For numerical raw data,
please see S1 Data. Arg1, Arginase-I; BMDMs, bone marrow–derived macrophages; Ccl2, C–C motif chemokine ligand 2; Cd206, cluster of differentiation 206; Fizz1,
found in inflammatory zone 1; IFNγ, interferon gamma; IL, interleukin; IRES, internal ribosome entry site; LPS, lipopolysaccharide; NO, nitric oxide; Nos2, nitric oxide
synthase 2; NS, non-significant; qRT-PCR, real-time quantitative reverse transcription PCR; TNFα, tumor necrosis factor alpha; YAP, yes-associated protein.
https://doi.org/10.1371/journal.pbio.3000941.g007
PLOS BIOLOGY Hippo pathway modulating macrophage polarization in injured heart
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000941 December 2, 2020 20 / 41
following MI. It is well established that macrophages are the predominant immune cells infil-
trating the infarcted myocardium and modulating both pro-inflammatory and anti-inflamma-
tory/reparative responses during the inflammatory and reparative phases of cardiac repair.
Therefore, understanding the dynamics of macrophage polarization will ultimately help to
modulate post-MI inflammation, resolution, and remodeling, and improve the heart’s ability
to repair itself after injury. Here, we demonstrate that the Hippo signaling mediators YAP and
TAZ can act both as transcriptional coactivators or corepressors during pro-inflammatory and
reparative macrophage polarization, respectively, and modulate post-MI inflammation and
remodeling by promoting pro-inflammatory and limiting reparative macrophage phenotype.
Several preclinical studies have demonstrated the involvement of macrophages in MI
pathophysiology [1–3]. The initial pro-inflammatory phase after MI is dominated by the
recruitment of pro-inflammatory macrophages that exhibit phagocytic, proteolytic, and
inflammatory functions. Here, we demonstrate that YAP/TAZ are essential for the macro-
phage-mediated initial inflammatory response. In addition, our RNA-seq analysis uncovers
numerous YAP/TAZ-dependent transcriptional changes that may play an important role in
different inflammatory diseases. Our global and candidate-based approaches demonstrate that
pro-inflammatory genes are positively regulated by YAP/TAZ. For example, in addition to
other pro-inflammatory genes, both IL6 and IL1β expressions are reduced in YAP/TAZ-defi-
cient BMDMs stimulated with LPS/IFNγ, as well as in YAP/TAZ-deficient macrophages from
the hearts after MI. Consistently, IL6 and IL1β expressions are elevated in BMDMs of trans-
genic mice expressing YAP5SA, a constitutively active form of YAP in macrophages. We fur-
ther demonstrate that YAP/TAZ can promote IL6 expression not only by directly binding to
TBSs in the IL6 promoter but also through the Tak1-p38 MAPKs signaling pathway. However,
the YAP/TAZ-mediated direct regulation of IL6 promoter seems to play a more dominant
role. YAP activation has been associated with increased IL6 production in previous studies
[58,59]. However, a direct regulation was not established. Consistent with our findings,
recently, Zhou and colleagues also identified TEAD-binding sites in human IL6 promoter and
showed direct regulation using a human leukemia monocytic cell line (THP-1 cells) [45]. We
also observed decreased number of pro-inflammatory (F4/80+iNOS+) macrophages and
increased number of reparative (F4/80+CD206+) macrophages in the YAP/TAZ-deficient
heart after MI suggesting that YAP/TAZ promote pro-inflammatory and limit reparative mac-
rophage fate. Several preclinical and clinical studies have shown that targeting pro-inflamma-
tory macrophages to suppress their pro-inflammatory response post-MI is cardioprotective.
For example, interferon regulatory factor 5 (IRF5) knockdown in macrophages shifts pro-
inflammatory to reparative phenotype to facilitate inflammation and improve cardiac healing
post-MI [25,28]. Similarly, knockdown of Ccr2 decreases macrophages recruitment to the
infarct site and reduces the pro-inflammatory response and infarct size [27]. Modulation of
recruited or resident cardiac macrophages from pro-inflammatory to anti-inflammatory state
using phosphatidylserine-presenting liposomes at a predetermined time after MI also reduces
adverse remodeling of the heart [24]. Consistent to these findings, our study also demonstrates
that genetic deletion or pharmacological inhibition of YAP/TAZ in macrophages reduces the
pro-inflammatory response, cardiac fibrosis, and protects cardiac function after MI suggesting
that YAP/TAZ can be considered as therapeutic targets to modulate macrophage phenotype in
diseased conditions.
In contrast to the early pro-inflammatory phase, the reparative/anti-inflammatory phase is
dominated by reparative macrophages as they actively participate in cardiac repair [24,60–63].
Previous studies have demonstrated that reparative macrophages facilitate repair response by
promoting myofibroblasts formation, neo-angiogenesis, and anti-inflammatory functions
[3,14–16,64]. The depletion of reparative macrophages leads to heart failure due to the lack of
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resolution of inflammation. This is evident by the increased number of inflammatory cells in
the infarct tissue and impaired left ventricular contractile function [7,65]. Here, we demon-
strate that YAP/TAZ inhibit reparative phenotype by repressing expression of reparative genes
such as Arg1. Expression of reparative genes such as Arg1, Ym1, Egr2, and Cd206 are increased
in YAP/TAZ-deficient BMDMs stimulated with IL4/IL13, as well as in YAP/TAZ-deficient
macrophages from the hearts at day 7 post-MI. Consistently, expression of Arg1 and other
reparative genes are decreased in BMDMs of transgenic mice expressing YAP5SA, a constitu-
tively active form of YAP in macrophages. In contrast to the recent finding by Zhou and col-
leagues that YAP expression is reduced during reparative macrophage polarization, we
observed increased YAP, pYAP, and TAZ expression after IL4/IL13 treatment in RAW264.7
cells, PMs, and BMDMs [45]. We further demonstrate that YAP/TAZ represses Arg1 expres-
sion by directly binding to the promoter and recruiting HDAC3-NCoR1 repressor complex.
We also demonstrate that YAP/HDAC3-mediated repression of Arg1 expression is indepen-
dent of the deacetylase activity of HDAC3. Both YAP and TAZ are well-established transcrip-
tional coactivators. However, their functions as transcriptional corepressors are not well
described. Two recent reports have demonstrated that YAP/TAZ recruits the nucleosome
remodeling and deacetylase (NuRD) complex to repress gene expression [66,67]. However,
YAP/TAZ interaction with the HDAC3-NCoR1 repressor complex has not been reported.
HDACs are recruited to the target gene promoters via their interaction with transcription fac-
tors, cofactors, and multiprotein coregulatory complexes often referred to as coactivators or
corepressors. For example, HDAC3 interacts with 2 major corepressor complexes, nuclear
receptor corepressor (NCoR) or its homolog silencing mediator of retinoic and thyroid recep-
tors (SMRT) to drive constitutive repression. A recent study suggests that HDAC3’s interac-
tion with NCoR/SMRT is essential for transcriptional repression and not its deacetylase
activity [55]. Similar to YAP/TAZ, HDAC3 is also required for promoting inflammatory gene
expression asHDAC3 deletion leads to reduced expression of LPS-induced pro-inflammatory
genes including IL6 [68]. Moreover, HDAC3 negatively regulates reparative macrophage
polarization, evident by increased expression of IL4-induced reparative genes including Arg1
in the BMDMs derived from macrophage-specific HDAC3 knockout mice [69]. In contrast to
some of the reparative gene analyzed,HDAC3 deletion did not alter the H3K9Ac or H3K27Ac
marks around the HDAC3 binding regions in Arg1 promoter suggesting that the deacetylase
activity of HDAC3 is not essential for Arg1 repression [69]. Similarly, macrophage-specific
deletion of NCoR causes impaired inflammatory response and increased anti-inflammatory
response resembling theHDAC3 knockout mice, demonstrating that HDAC3 interaction with
NCoR is essential for its role in macrophage polarization [70]. A recent study by Zhou and col-
leagues demonstrated that YAP inhibits reparative macrophage polarization by promoting
expression of transcriptional factor p53, a negative regulator of reparative macrophage polari-
zation [45]. p53 expression is increased during both pro-inflammatory or reparative macro-
phage polarization but more prominent in pro-inflammatory macrophages compared to
reparative macrophages [49]. Previous studies have demonstrated that p53 negatively regulates
activation of both pro-inflammatory (IL6, TNFα, etc.) and reparative (Arg1, Fizz1, Irf4, etc.)
marker genes [49,71,72]. In contrast to the finding by Zhou and colleagues, we did not observe
any significant changes in p53 expression in YAP/TAZ-deficient BMDMs during pro-inflam-
matory or reparative macrophage polarization. Together, our results suggest that depending
upon the biological context YAP/TAZ can act as transcriptional coactivators or corepressors
[67].
Reparative macrophages also secrete anti-inflammatory and pro-fibrotic cytokines (e.g., IL-
10 and TGF-β) to suppress inflammation and promote tissue repair. These cytokines by modu-
lating (myo)fibroblast activation and collagen deposition [1]. IL-10 is produced by
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macrophages as a negative feedback mechanism to dampen the production of inflammatory
cytokines and minimize the deleterious effects after MI. We observed decreased expression of
both IL-10 and TGF-β in YAP/TAZ-deficient hearts at day 7 post-MI. Our results are consis-
tent with a previous study demonstrating improved cardiac dysfunction and cardiac fibrosis in
macrophage-specific IL-10 knockout mice [1]. Reduced fibrosis in post-MI YAP/TAZ-dKO
hearts is also associated with reduced formation of myofibroblasts. This is evident by decreased
expression of Acta2 and Taglnmarking stress fibers. Additionally, genes essential for collagen
synthesis and its processing were also down-regulated in YAP/TAZ-dKO hearts. We speculate
that reduced myofibroblasts activation and collagen production result from reduced expres-
sion of IL-10 and TGF-β in YAP/TAZ-dKO hearts and early shift of pro-inflammatory to
reparative phenotype. Both processes lead to reduced tissue damage and adverse remodeling.
Previous findings suggest that macrophage-mediated reparative/anti-inflammatory signaling
alone determines the infarct repair [63]. However, our results demonstrate that both YAP/
TAZ-dependent pro-inflammatory and reparative/anti-inflammatory responses are essential
for limiting the infarct size and repair.
In addition to regulating pro-inflammatory and reparative responses, macrophages enhance
neovascularization by secreting a variety of pro-angiogenic growth factors including Vegf and
Vcam1. Using a reporter mouse line, Willenborg and colleagues demonstrated thatVegf expres-
sion by macrophages is required to induce capillary sprouting during wound healing [73]. Recent
studies have shown that signals derived from macrophages are necessary to drive angiogenesis
during cardiac regeneration [4,5]. Consistent with these findings, we also observed enhanced
expression ofVegf andVcam1 in YAP/TAZ-dKO post-MI hearts, suggesting improved revascular-
ization of the infarct tissue. Increased number of CD31 and Emcn-positive blood vessels as well as
increased lectin-positive capillary density in the infarcts of YAP/TAZ-dKO hearts support this
notion. Improved cardiac hypertrophy is associated with cardiac recovery after MI. Here, we
observed a reduced expression of hypertrophy genes (such asMyh7,Nppa, andNppb) and cardio-
myocyte size in YAP/TAZ-dKO infarcted heart compared to controls as evident by WGA, indicat-
ing an improvement of cardiac remodeling post-MI. Collectively, these findings demonstrate that
the deletion of YAP/TAZ in macrophages reduces inflammation and enhances repair, while
simultaneously promoting angiogenesis in the injured cardiac tissue.
Growing evidence suggests that an early shift in macrophage polarization from the pro-
inflammatory phase to the reparative phase is essential for successful cardiac repair
[24,25,27,28]. In the present study, we demonstrate that YAP/TAZ are essential for regulating
macrophage polarization and post-MI response. Deletion of YAP/TAZ attenuates early inflam-
matory response and promotes timely polarization of pro-inflammatory macrophages to
reparative macrophages. These changes lead to mitigated adverse remodeling and improved
cardiac function after MI. Our results demonstrate that YAP/TAZ are promising targets for
modulating macrophage polarization and improving cardiac repair after MI. Since macro-
phages can take up foreign particles, they are easy and selective targets. This represents a pre-
cious opportunity for therapeutic intervention to prevent adverse cardiac remodeling and
physiological deterioration of the infarcted hearts.
Materials and methods
Ethics statement
All animal procedures were approved (IACUC protocol No. 2019/SHS/1461 and 2018/SHS/
1415) by the Institutional Animal Care and Use Committee at Duke-NUS Medical School/Sin-
ghealth conforming to the Guide for the Care and Use of Laboratory Animals (National Acad-
emies Press, 2011).
PLOS BIOLOGY Hippo pathway modulating macrophage polarization in injured heart
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000941 December 2, 2020 23 / 41
Mice
Myeloid cell-specific YAP/TAZ-dKO mice were generated by crossing the LysMCre/+ transgenic
mice with YAPflox/flox;TAZflox/floxmice [74–76]. The resulting LysMCre/+;YAPflox/+;TAZflox/+ off-
spring were then backcrossed to YAPflox/flox;TAZflox/flox strain to obtain LysMCre/+;YAPflox/flox;
TAZflox/flox (YAP/TAZ-dKO) mice. We used YAPflox/flox;TAZflox/floxmice as control. YAP and
TAZ floxed mice were genotyped as described previously [74,75]. Similarly, for YAP activation
in myeloid cells, LysMCre/+mice were crossed with Rosa26YAP5SA/YAP5SA knock-in strain to gen-
erate LysMCre/+;Rosa26YAP5SA/+mice [77]. We used Rosa26YAP5SA/+mice as control.
Rosa26YAP5SA/YAP5SAmice were genotyped as described previously [77]. All mice were main-
tained on a mixed (C57BL/6 and Sv/129) genetic background. Both male and female mice were
used in the experiments. All animals were kept in ventilated cages (up to 5 mice per cage) in a
12-hour light–dark cycle and were provided water and food at all times. All animal procedures
were approved (IACUC protocol No. 2019/SHS/1461 and 2018/SHS/1415) by the Institutional
Animal Care and Use Committee at Duke-NUS Medical School/Singhealth conforming to the
Guide for the Care and Use of Laboratory Animals (National Academies Press, 2011).
Myocardial infarction surgery and echocardiography
MI surgery was done as described previously [78]. Briefly, control and YAP/TAZ-dKO mice
were subjected to permanent ligation of left anterior descending (LAD) coronary artery to
induce MI in aseptic conditions. At first, mice were anesthetized with isoflurane, fixed in a
supine position with tape. Their neck and chest were shaved and applied with an antiseptic
solution. Toe pinch reflexes were performed to observe the depth of anesthesia. The tongue
was retracted, and a 20-gauge IV catheter was quickly inserted into the trachea. The catheter
was connected to the small animal ventilator through a Y-shaped connector. Mice were then
ventilated with an adjusted stroke volume and a respiratory rate of 100 to 110 breaths/min.
Next, thoracotomy was performed, and the suture was inserted through the LV of exposed
heart. To induce MI, a permanent ligation was obtained by tying an 8–0 silk suture around the
LAD. The echocardiographic assessment was conducted at 28 days post-MI to evaluate the car-
diac function. Hearts were harvested at 2, 3, 6, 7, and 28 days post-MI for histology, qRT-PCR,
FACS, and immunohistochemistry. Transthoracic echocardiography (TTE) was conducted
with Vevo 2100 (VisualSonics, VSI, Toronto, Canada) by using a MS400 linear array trans-
ducer, 18 to 38 MHz. All mice were anesthetized with 5% isoflurane and maintained at 0.6% to
1%. An average of 10 cardiac cycles of standard 2-dimensional (2D) parasternal long and short
axis (mid papillary muscle level), as well as pulsed-wave Doppler recording of the mitral
inflow, were acquired and stored for subsequent offline analysis. LVEDV and LVESV were
determined at the parasternal long axis. SV was obtained by subtracting ESV from EDV. Left
ventricular internal diameter at end-systole (LVIDes) and end-diastole (LVIDed) were
recorded from the 2D guided M-mode of the short axis at the mid papillary muscle level. Sub-
sequently, LVEF and FS were calculated using the modified Quinone method as described
before [79,80]. IVRT was obtained with pulsed-wave Doppler of the mitral valve at the apical 4
chamber view and was corrected for heart rate (IVRTc) as calculated to the formula
(IVRT = IVRT/
p
RR%). All measurements were averaged on 3 cardiac cycles by a blinded
operator.
Histology and immunohistochemistry
Histology and immunohistochemistry were performed as described previously. Briefly, adult
hearts were dissected in PBS and fixed in 4% paraformaldehyde overnight at 4˚C. Hearts were
then washed with PBS, dehydrated in an ethanol series, and stored in 100% ethanol at −-20˚C.
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Paraffin sections were prepared for Masson’s trichrome, WGA, MPO, CD31, Lectin, and
Emcn immunostaining. Collagen immunostaining was performed on cryosections. For immu-
nostaining, sections were permeabilized with 0.1% Triton-X-100 in PBS and processed for
antigen retrieval using antigen unmasking solution (Vector Laboratories, United States of
America). Endogenous peroxidase activity was blocked with 3% H2O2 10 minutes at room
temperature. The cryo/paraffin heart sections were blocked for 1.5 hours using 5% BSA or
10% normal goat/donkey serum. After washing with PBS, sections were incubated with pri-
mary antibodies diluted in blocking buffer at 4˚C overnight. Sections were washed and then
incubated with secondary antibody (HRP-conjugated or Alexa Fluor conjugated) diluted in
blocking buffer for 1.5 hours at room temperature. Sections were washed again and developed
using the DAB kit (Vector Laboratories, catalog no. SK-4100) or DAPI (for IF) in PBS for 15
minutes. After washing, sections were mounted with 100% glycerol, and the staining pattern
was visualized with a Leica fluorescence microscope (LEICA DMi8, Leica Microsystems
(SEA), Singapore).
Cell culture
BMDMs were isolated from the femurs and tibiae of control and YAP/TAZ-dKO mice. Femurs
and tibiae were collected by cutting off the hind legs at the hip joint with sterile scissors, ensur-
ing that joints were kept intact, and placed in sterile cold PBS. The excess muscle was removed
carefully by leaving the bone with no muscle. Using sharp scissors soaked in 95% ethanol, the
ends of the bones were cut. The bone cavity containing BMDMs was flushed out with 5 ml of
sterile cold PBS. Cells were then centrifuged at 1,000 rpm for 10 minutes for pellet collection.
Pellets were resuspended and plated in 20 ml of macrophage medium [Dulbecco’s Modified
Eagle Medium (DMEM) (Gibco, Thermo Fisher Singapore, catalog no. 11965092) containing
20% L929-conditioned medium, 1% penicillin/streptomycin, and 10% FBS]. On day 3, an
additional 15 ml of macrophage medium was added, and on day 6, all the media were replaced
with fresh macrophage media. On day 7, cells were detached using trypsin (Gibco, catalog no.
25200056) for 30 minutes to 1 hour at 4˚C. Cells were then washed, centrifuged, resuspended
and seeded (1 × 106 cells/well) in a 6-well tissue culture plates using the culture medium
(DMEM containing 10% FBS and 1% penicillin/streptomycin). CD11b-FITC (Miltenyi Biotec,
Germany, catalog no. 130-098-085) and APC anti-mouse F4/80 (BioLegend, USA, catalog no.
123115) antibody-based flow cytometry were used to evaluate the macrophage (BMDMs and
PMs) culture purity. We observed nearly 99.69% and 97.63% purity for BMDMs and PMs,
respectively. Also, CD68 immunostaining was performed to evaluate the macrophage culture
purity. BMDMs were subsequently treated with pro-inflammatory (LPS 100 ng/ml + IFNγ 10
ng/ml), reparative/M2a stimuli (IL4 10 ng/ml + IL13 10 ng/ml), reparative/M2b (100 μg/ml
anti-BSA + 10 μg/ml BSA), and reparative/M2c (IL10 10 ng/ml + TGFβ1 10 ng/ml) for desired
time points with appropriate controls. IFNγ (catalog no. 575306), IL4 (catalog no. 574304),
IL13 (catalog no. 575902), and TGFβ1 (catalog no. 763102) were obtained from BioLegend
and LPS (catalog no. L3129) from Sigma-Aldrich, Singapore. IL10 (catalog no. ab9736) was
obtained from Abcam, USA, and anti-BSA (catalog no. SAB4301142) was obtained from
Merck, Singapore. PMs were harvested from wild-type mice treated with an intraperitoneal
injection of 3% Brewer thioglycollate medium. PMs were harvested 4 days after thioglycollate
injection and cultured and maintained using conditions similar to BMDMs, described above.
RNA interference
Control (AllStars Negative siRNA AF488, catalog no. 1027284), YAP siRNAs (catalog no.
GS22601), and TAZ siRNA (catalog no. SI01442511 and SI01442532) were obtained from
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Qiagen, USA. HDAC3 silencer pre-designed siRNA (catalog no. AM16708) and silencer nega-
tive control siRNA (catalog no. AM4620) were purchased from Invitrogen, USA. The siRNA
was transfected in BMDMs using Lipofectamine RNAiMAX transfection reagent (Thermo
Fisher, Singapore, catalog no. 13778150). Briefly, after a transient transfection, BMDMs were
incubated for 72 hours and treated with either pro-inflammatory (LPS 100 ng/ml + IFNγ 10
ng/ml) or reparative stimuli (IL4 10 ng/ml + IL13 10 ng/ml) diluted in culture medium
(DMEM containing 10% FBS and 1% penicillin/streptomycin). Cells were collected for total
RNA isolation and qRT-PCR analysis using Favorgen RNA extraction kit (Favorgen Biotech,
Taiwan, catalog no. FATRK 001–2). Cell lysates were prepared using RIPA buffer (Thermo
Fisher, catalog no. 89901) for western blot analysis.
Macrophage migration assay
BMDMs (1 × 105 cells) from control and YAP/TAZ-dKO mice were added to the upper cham-
ber of a 6.5-mm Transwell plate system with 8-μm pore polycarbonate membrane insert. The
lower chamber of the Transwell plate was loaded with macrophage medium containing LPS/
IFNγ, and the BMDMs were allowed to migrate for 12 hours. The cells that migrated into the
lower chamber media were fixed with 4% PFA and subsequently stained with CD68 and DAPI
and quantified with ImageJ software (NIH, USA).
Neutrophil isolation and migration assay
Control and YAP/TAZ-dKO mice were injected intraperitoneally with a dose of LPS (2 mg/kg)
as diluted in PBS. Neutrophils were isolated from mouse bone marrow at 16 hours post-injec-
tion as described previously [81]. Neutrophils (1 × 104 cells) from control and YAP/TAZ-dKO
mice were added to the upper chamber of a 6.5-mm Transwell plate system with 8-μm pore
polycarbonate membrane insert. The lower chamber of the Transwell plate was loaded with
neutrophil medium containing RPMI 1640 supplemented with 10% FBS and 1% penicillin/
streptomycin. Neutrophils were allowed to migrate for 6 hours, and the cells that migrated
into the lower chamber were fixed with 4% PFA and subsequently stained with myeloperoxi-
dase (MPO) and DAPI and quantified with ImageJ software.
Plasmids
Mouse IL6 promoter (approximately 2 kb) was amplified and cloned into a pGL4.27 vector
(Promega, Singapore) for luciferase assays. For mutation of TBSs in IL6 promoter, 3 promoter
fragments (Pro-I, Pro-II, and Pro-III) were amplified and cloned into pGL4.27 vector and
used as control. Mini genes for the same promoter fragments differing only by the presence of
mutated TBSs were purchased from Integrated DNA Technologies (IDT, USA)) and subse-
quently cloned into pGL4.27 vector. In Pro-I promoter fragment, TBSs AGAATG, TGCATG,
and TGAATG were mutated to ACAAAC, TCCAAC, and TCAAAC, respectively. In Pro-II
promoter fragment, TBSs TAGTATG, AAGAATG, TGAATG, and TGTATG were mutated to
TACTAAC, AACAAAC, TCAAAC, and TCTAAC, respectively. Similarly, in Pro-III pro-
moter fragment, TBSs TGTATG, CGTATG, and AGCATG were mutated to TCTAAC,
CCTAAC, and ACCAAC, respectively. Mouse YAP and TAZ expression vectors for the lucif-
erase assay have been previously described [82]. Other plasmids used in this study were the fol-
lowing: pCMV5-Flag-HDAC3 was a gift from Qingbo Xu and Lingfang Zeng (Addgene
plasmid # 63676) [83]. pGL3-mArg1 promoter/enhancer −31/−3810 was a gift from Peter
Murray (Addgene plasmid # 34571) [84]. pCMV-flag YAPS127A was a gift from Kunliang Guan
(Addgene plasmid # 27370) [57]. NFкB luciferase reporter (Promega, catalog no. E849A).
HDAC3 and HDAC3H134A, H135A was a gift from Chinmay Trivedi [56].
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Luciferase assay
Luciferase assay was performed as previously described [41]. Briefly, HEK293T cells were
maintained in DMEM supplemented with 10% FBS and 1% P/S. HEK293T cells were seeded
in 12-well plates for 24 hours before transfection. The IL6 or Arg1 luciferase reporter plasmid
and other indicated plasmids (YAP, TAZ, or HDAC3) were co-transfected in desired concen-
trations using FuGENE6 reagent (Promega, catalog no. E2691). To normalize transfection effi-
ciency, 50 ng of lacZ expression plasmid was also transfected along with other indicated
plasmids. Sixty hours post-transfection, cells were lysed and extracted with lysis buffer (Pro-
mega, catalog No. E3971). Next, luciferase activities were measured using the Luciferase
Reporter Assay System kit (Promega, catalog no. E1500). Cell lysates were also evaluated for β-
galactosidase activity using the β-Galactosidase Enzyme Assay System (Promega, catalog no.
E2000). Luciferase reporter activity was then normalized to β-galactosidase activity. The lucif-
erase assay was repeated in at least 3 independent experiments and duplicates. Representative
data are shown in the figures. The inhibitors used in the luciferase assay were SB203580 (Sell-
eck Chemicals, USA, catalog no. S1076), RGFP966 (Selleck Chemicals, catalog no. S7229),
Vorinostat (Selleck Chemicals, catalog no. S1047), and Scriptaid (Sigma, catalog no. S7817).
Luciferase assay with HDAC3 deacytylase mutant, lentiviral particles were prepared using
HDAC3 and HDAC3H134A, H135A plasmids. HEK293T cells were seeded in 12-well plates for
24 hours before transfection. The Arg1 luciferase reporter plasmid was co-transfected with
YAP expression plasmid and 50 ng of lacZ expression plasmid for normalization. Twenty-four
hours after transfection, cells were infected with either HDAC3 or HDAC3H134A, H135A lentivi-
rus. Infected cells were harvested for luciferase reporter analysis 48 hours after infection using
the Luciferase Reporter Assay System kit and β-Galactosidase Enzyme Assay System.
Bacteria killing assay
To determine the bactericidal ability of macrophages, 2 × 105 gram-negative (E. coli) or 2 × 105
gram-positive (L.monocytogenes) bacteria were incubated with BMDMs for 2 hours. Cells
were then thoroughly washed with PBS for 3 to 5 times and incubated for 16 to 24 hours in
DMEM containing antibiotics before harvesting for intracellular bacteria. Subsequently, cell
lysate from macrophages containing intracellular bacteria was serially diluted with PBS and
spread onto agar plates to determine bacterial viability (expressed as CFU). For qRT-PCR anal-
ysis, total RNA was prepared using Favorgen RNA extraction kit (Favorgen Biotech, catalog
no. FATRK 001–2).
Flow cytometry and FACS
Infarcted LV tissues excised from day 2 (to isolate pro-inflammatory macrophages) and day 6
(to isolate reparative macrophages) post-MI mice were digested with 600 U/ml collagenase II
(Thermo Fischer, catalog no. 17101015), DNase I 60 U/ml (Thermo Fischer, catalog no.
EN0521), and 5% FBS in Hanks buffered saline solution (Thermo Fischer, catalog no.
14175095) at 37˚C with shaking for 20 minutes. Cells suspension was then filtered through a
30-μM separation filter, and suspended cells were transferred to FACS tube. Isolated cells were
centrifuged and washed with 2% FBS in PBS buffer and blocked with FcR blocking reagent
(Miltenyi, catalog no. 130-092-575) for 15 minutes at 4˚C. Next, cells were stained with PE-
conjugated F4/80 (1:100; Invitrogen, catalog no. 12-4801-82), Alexa Fluor 448-conjugated
iNOS (1:50; Santa Cruz, USA catalog no. sc-7271), and Alexa Fluor 700-conjugated CD206
(1:100; BioLegend, catalog no. 141734) antibodies to obtain pro-inflammatory and reparative
macrophages. iNOS+/F4/80+ macrophages were considered as pro-inflammatory macro-
phages, and CD206+/F4/80+ macrophages were considered as reparative macrophages. Flow
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cytometric analyses and macrophage sorting were performed by using a FACSAria II cell
sorter (BD Bioscience, Singapore).
In vitro nitrite level
Nitrite resulting from NO was examined in BMDMs conditioned medium with Griess Reagent
System (Promega, catalog no. G2930) according to manufacturer’s instructions.
Protein extraction and western blot
Cells were washed twice with cold DPBS (Lonza, Switzerland, catalog no. 17-512F) and lysed
with RIPA buffer (Thermo Scientific, catalog no. 89901) containing 1:100 diluted protease and
phosphatase inhibitor cocktail (Sigma). The cell lysates were centrifuged at 13,000 rpm for 10
minutes at 4˚C, and the supernatants were collected. Total protein concentration was deter-
mined with the Pierce BCA protein assay kit (Thermo Scientific, catalog no. 23225) following
the manufacturer’s instructions. Next, 20 to 30 μg of total protein samples were separated by
SDS-PAGE and transferred to nitrocellulose membrane using Trans-Blot Turbo system (Bio-
Rad, Singapore). Membranes were then blocked with 2% to 5% BSA in TBS containing 0.1%
Tween (TBST) and subsequently incubated with primary antibodies diluted in TBST contain-
ing 2% to 5% BSA for overnight at 4˚C. Blots were then washed in TBST and incubated for 1.5
hour at room temperature probed with the appropriate horseradish peroxidase linked IgG
(Santa Cruz). Immunoreactive bands were detected by chemiluminescence (Hiss GmbH, Ger-
many, catalogue no. 16026) using Gel Doc XR+ System (Bio-Rad).
Antibodies
The following antibodies were used for western blotting and immunostaining: YAP (Santa
Cruz, catalog no. sc-376830 and Sigma, catalog no. Y4770), pYAP (Ser127) (Cell Signaling,
Catalog no. 4911), TAZ (Santa Cruz, catalog no. sc-48805 and Santa Cruz, Catalog no. sc-
518026), IL6 (Santa Cruz, catalog no. sc-57315), Nos2 (Santa Cruz, catalog no. sc-7271),
HDAC3 (Santa Cruz, catalog no. sc-376957), NCoR1 (Thermo Fisher, catalog no. PA1-844A),
Myc (Sigma, Catalog no. C3956), FLAG (Sigma, Catalog no. F1804), IL1β (Santa Cruz, catalog
no. sc-7884), Arg1 (Santa Cruz, catalog no. sc-166920), Collagen I (Novus Biologicals, USA,
catalog no. NB600-408), Emcn (Santa Cruz, catalog no. sc-65495), CD31 (BD Bioscience, cata-
log no. 553370), Ki67 (Abcam, catalog no. ab16667), CD68 (AbD Serotec, United Kingdom,
catalog no. MCA1957), TGFβ (Cell Signaling, Catalog no. 3711), β-galactosidase (MP Biome-
dicals, USA, catalog no. 863365), β-actin (Santa Cruz, catalog no. sc-47778), PCNA (Santa
Cruz, catalog no. sc-56), WGA (Thermo Fisher, catalog no. W11261), Lectin (Thermo Fisher,
catalog no. L21409), and Myeloperoxidase (Abcam, catalog no. ab9535).
RNA isolation, cDNA synthesis, and qRT-PCR
Total RNA from heart tissues (left ventricles) and BMDMs were isolated using TRIzol (Life
Technologies, Singapore, catalog no. 15596018) and Favorgen RNA extraction kit (Favorgen
Biotech, catalog no. FATRK 001–2), respectively. The concentration and quality of RNA were
measured with UV spectrophotometry (NanoDrop Technologies, Wilmington, North Caro-
lina, USA). For cDNA synthesis, total RNA was reverse transcribed using random hexamers
and SuperScript III FirstStrand Synthesis system (Life Technologies, catalog no. 18080–051).
Gene expression was performed by quantitative RT-PCR (ABI PRISM 7900 or ViiA7 Real-
Time PCR System) using 10-μl reaction mixture containing 20 ng cDNA, SYBR Green Master
Mix (Life Technologies, catalog no. 4368702), 6-μM forward primer, and 6-μM reverse primer.
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Results were analyzed with Real-Time PCR System Software (Applied Biosystems, Singapore).
All mRNA data were normalized against the reference gene Gapdh.
RNA-seq
To perform the RNA-seq, total RNA was prepared from BMDMs of control and YAP/TAZ-
dKOmice using either Favorgen RNA extraction kit (Favorgen Biotech, catalog no. FATRK
001–2) or PureLink RNA Mini Kit (Thermo Fisher, catalog no. 12183018A). Subsequently,
strand-specific poly(A) RNAseq libraries were generated using NEBNext Ultra II Directional
RNA Library Prep Kit for Illumina (NEB,Singapore, catalog no. E7765S) and sequenced on
Hiseq2000 sequencer. The average sequencing depth was >30 million reads per sample.
Paired-end RNA sequencing reads from each sample were aligned to the mouse reference
genome (GRCm38) via STAR aligner (version 2.5.1b) with an average mapping rate of 81%
[85]. Mapped sequencing reads were quantified and assigned to genomic features via the fea-
tureCount option in R package Rsubread [86]. Differential gene expression analysis was con-
ducted in R via limma [87]. Genes with absolute log fold change >1.0 and false discovery rate
(FDR) <5% were considered differentially expressed. Common and unique sets of differen-
tially expressed genes were identified through Venn diagrams (http://bioinfogp.cnb.csic.es/
tsools/venny/index.html). Transcriptome data were further analyzed for enrichment of biolog-
ical pathways by querying “gene-sets” from the Kyoto Encyclopedia of Genes and Genomes
(KEGG) [88] or Gene Ontology [89] pathway repositories via the PreRankedGSEA [90] or
Enrichr overrepresentation analysis tools [91].
ChIP assay
ChIP assay was performed as previously described [41]. In brief, BMDMs were stimulated
with LPS/IFNγ (100 ng/ml + 10 ng/ml) or IL4/IL13 (10 ng/ml) for 12 hours and subsequently
cross-linked for 10 minutes with 1% formaldehyde at room temperature. Cells were then col-
lected in ice-cold PBS and processed for ChIP using Millipore Assay Kit (Millipore, Germany,
catalog no. 17–295). ChIP grade YAP and TAZ antibody were used for the assay (Cell Signal-
ing, catalog no. 14074S, and 4883S). Rabbit IgG was used as a negative control. IL6 promoter
PCR was performed with the following primers (sense: GGTGAAAGAATGGTGGACTCA;
antisense: CATTCTCCCCAGTGGTCTCT). Arg1 promoter PCR was performed with the fol-
lowing primers (sense: GGAGGCAGGCGATACTTTAAT; antisense:
ACAGACTCCCCACGTTACCA).
Co-immunoprecipitation
To examine the protein–protein interaction, RAW 264.7 cells were transfected with plasmid
expressing Myc-YAP and FLAG-HDAC3 using lipofectamine transfection reagent (Thermo
Fischer, catalog no. 11668019) according to the manufacturer’s protocol. Following transient
transfection, cells were incubated for 48 hours and starved for 8 hours with serum-free DMEM
supplemented with 1% penicillin/streptomycin. Cells were then treated with reparative macro-
phage-stimuli (IL4 10 ng/ml + IL13 10 ng/ml) for 12 hours. Cell lysates were collected for co-
immunoprecipitation using protein extraction reagent. The cells extracts were then incubated
with anti-Myc (1:100; Sigma, Catalog no. F1804) at 4˚C overnight, and immunoprecipitation
was performed using protein A/G-agarose beads immunoprecipitation reagents (Santa Cruz,
catalog no. sc-2003). Samples were then run on SDS-PAGE and probed with anti-FLAG
(1:2000; Sigma, Catalog no. F1804) and anti-Myc (1:2000; Sigma, Catalog no. C3956), antibod-
ies at 4˚C overnight to detect them as co-precipitated protein. In a separate experiment,
BMDM cells were treated with reparative macrophage-stimuli (IL4 10 ng/ml + IL13 10 ng/ml)
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for 12 hours and performed co-immunoprecipitations with anti-YAP (1:50, Cell Signaling,
Catalog no. 14074S) and immunoblotted for NCoR1 (1: 500; Thermo Fisher, catalog no. PA1-
844A), anti-HDAC3 (1: 500; Santa Cruz, catalog no. sc-376957), and anti-YAP (1: 1000;
Sigma, catalog no. Y4770). The immune complexes were detected using ECL reagent (GE
Healthcare, USA, catalog no. RPN2235).
Fibrosis image analysis
The amount of post-MI myocardial fibrosis in control and mutant mice was quantified using
ImageJ. Briefly, serial sections starting from the coronary ligature to the cardiac apex were
stained with Masson’s trichrome to determine the fibrotic tissue. At least 5 cross-sectional
images for each heart were analyzed for blue myocardium (fibrotic tissue), followed by the
total heart. Statistical differences in the percentage of fibrosis were determined with the
unpaired t test.
Statistical analysis
Experimental data are presented as mean ± standard error mean (SEM) from at least 3 inde-
pendent experiments. Data from luciferase experiments are presented as mean ± standard
deviation (SD). Results were analyzed with unpaired t test within 2 groups if both groups were
normally distributed. Differences were considered significant when the p-value was < 0.05.
Comparisons among 3 or more groups were performed using 1-way ANOVA, followed by
multiple comparison test. (�, p< 0.05; ��, p< 0.01; ���, p< 0.001; NS, not significant). Statisti-
cal analyses were performed using Graph-Pad Prism v.5 (GraphPad Software, USA).
Supporting information
S1 Fig. YAP/TAZ expression is activated by pro-inflammatory or reparative macrophage-
stimuli in wild type BMDMs. BMDMs were isolated from wild-type mice and stimulated
with/without LPS/IFNγ or IL4/IL13 for 0, 8 and 12 hours, respectively. Western blot analysis
for YAP and TAZ was performed using the nuclear fraction of BMDMs. PCNA is shown as a
loading control. The relative expression was quantified. Western blot analysis for pYAP was
performed using the cytoplasmic fraction of BMDMs. Β-actin is shown as a loading control.
The relative expression was quantified. For numerical raw data, please see S1 Data.
(PDF)
S2 Fig. Characterization of BMDMs polarization into pro-inflammatory and reparative
macrophages. (A) BMDMs and PMs were isolated from wild-type mice and stimulated with/
without LPS/IFNγ for 0, 4, 8, and 12 hours, respectively. Western blot analysis for TGFβ using
cell lysates of BMDMs and PMs. Vinculin is shown as a loading control. The relative expres-
sion was quantified. (B) BMDMs and PMs were isolated from wild-type mice and stimulated
with/without LPS/IFNγ for 12 hours. Real-time qPCR for reparative marker genes, Vegf and
Tgfβ, using RNA isolated from untreated or LPS/IFNγ-treated macrophages. (C) BMDMs
were isolated from wild-type mice and stimulated with/without IL4/IL13 for 0, 4, 8, and 12
hours, respectively. Western blot analysis for IL6 using cell lysates of BMDMs. Vinculin is
shown as a loading control. The relative expression was quantified. For numerical raw data,
please see S1 Data.
(PDF)
S3 Fig. Knockdown of TAZ decreases pro-inflammatory and increases reparative macro-
phage phenotype. (A–C) BMDMs were isolated from wild-type mice and transfected with
control or TAZ siRNA for 72 hours, followed by LPS/IFNγ or IL4/IL13 stimulation for 16
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hours. Cell lysates were prepared for western blot and qRT-PCR analysis. (A) Western blot
analysis for TAZ, IL6, and Nos2 was performed using total lysates from wild-type BMDMs
transfected with control or TAZ siRNA. Vinculin is shown as a loading control. The relative
expression was quantified. (B) Real-time qPCR for pro-inflammatory marker genes IL6, IL1β,
and Nos2 using RNA isolated from wild-type BMDMs transfected with control or TAZ siRNA
and stimulated with LPS/IFNγ. (C) Real-time qPCR for reparative marker genes Arg1, Ym1,
and Fizz1 using RNA isolated from wild-type BMDMs transfected with control or TAZ siRNA
and stimulated with IL4/IL13. (D) Real-time qPCR for IL6, IL1β, and Nos2 using RNA isolated
from BMDMs treated with either DMSO, LPS/IFNγ, or LPS/IFNγ together with verteporfin
(VP). Data are shown as the mean ± SEM, n = 3 for each experimental group. Gene expression
data were normalized with the reference gene Gapdh, and results are represented as fold
change relative to the control treatment. For numerical raw data, please see S1 Data.
(PDF)
S4 Fig. Efficiency of YAP/TAZ deletion in macrophages. (A) Real-time qPCR for YAP and
TAZ using RNA isolated from control and YAP/TAZ-dKO BMDMs. n = 3 in each group. (B)
Western blot analysis for YAP and TAZ was performed using total lysates from control and
YAP/TAZ-dKO BMDMs. Vinculin is shown as a loading control. For numerical raw data,
please see S1 Data.
(PDF)
S5 Fig. Characterization of isolated BMDMs and PMs. (A and B) Isolated BMDMs (A) and
PMs (B) were stained with CD11b-FITC and APC anti-mouse F4/80 antibodies, and their
purity were evaluated by flow cytometry analysis. (C and D) Representative flow cytometry
analysis of pro-inflammatory (iNOS+/F4/80+) and reparative (CD206+/F4/80+) macrophages
in total macrophages from the 2 and 6 days post-MI hearts, respectively; showing the percent-
age of F4/80+iNOS+ and F4/80+CD206+ macrophages in YAP/TAZ-dKO hearts compared to
respective control.
(TIF)
S6 Fig. BMDMs proliferation and migration is not affected due to YAP/TAZ deletion. (A)
To assess changes in BMDMs proliferation, cultured BMDMs were stimulated with LPS/IFNγ
and immunostained with CD68 and Ki67. DAPI was used to stain nuclei. Scale bar 100 μM.
(B) Quantification of CD68 and Ki67 double-positive BMDMs from control and YAP/TAZ-
dKO mice. (C) Migration of control and YAP/TAZ-dKO BMDMs was examined by a transwell
assay. Cells that had migrated to the lower chamber of the transwell plate were visualized by
CD68 immunostaining. DAPI was used to stain nuclei. Scale bar 50 μM. (D) Quantification of
CD68 positive BMDMs from control and YAP/TAZ-dKO mice migrated to the lower chamber
of the transwell plate. For numerical raw data, please see S1 Data.
(PDF)
S7 Fig. Changes in inflammatory gene expression due to YAP/TAZ deletion. MA plots for
pathways identified from pathway enrichment analysis of the RNA-seq data from untreated or
LPS/IFNγ treated control and YAP/TAZ-dKO BMDMs. For numerical raw data, please see S1
Data.
(PDF)
S8 Fig. Effect of YAP on the expression of inflammatory genes. Two luciferase reporters
(NF-kB-Luc and IL6-Luc) were used with YAP in the presence or absence of Hippo signaling
inhibitor verteporfin (VP) or MAPK inhibitor SB203580. (A) Results of normalized luciferase
reporter assays in HEK293T cells with NF-кB-luciferase reporter in the presence of YAP. (B)
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IL6-luciferase reporters were transfected in HEK293T cells with or without YAP in the pres-
ence or absence of VP or SB203580. All the experiments repeated at least 3 times. For numeri-
cal raw data, please see S1 Data.
(PDF)
S9 Fig. Expression of reparative macrophage subset marker genes in control and YAP/
TAZ-dKO BMDMs. (A–C) BMDMs were isolated from control and YAP/TAZ-dKO mice and
stimulated with/without IL4/IL13 (M2a) or BSA/anti-BSA immune complex (M2b) or IL10/
TGFβ1 (M2c) for 24 hours. Real-time qPCR was performed for (A) M2a (Ym1 and Cd206),
(B) M2b (Il10 and Il1ra), and (C) M2c (Mmp9 and TGFβ) marker genes using RNA isolated
from control and YAP/TAZ-dKO BMDMs. Data are shown as the mean ± SEM, n = 3 for each
experimental group. Gene expression data were normalized with the reference gene Gapdh,
and results are represented as fold change relative to the control treatment. For numerical raw
data, please see S1 Data.
(PDF)
S10 Fig. p53 expression was not affected in YAP/TAZ-dKO BMDMs during pro-inflamma-
tory or reparative macrophage polarization. (A) Relative expression (FPKM) of Trp53 from
RNA-seq analysis on control and YAP/TAZ-dKO BMDMs treated with LPS/IFNγ. (B and C)
Western blot analysis and quantification for p53 were performed using total lysates from con-
trol and YAP/TAZ-dKO BMDMs stimulated with IL4/IL13 for 24 hours. β-actin is shown as a
loading control. For numerical raw data, please see S1 Data.
(PDF)
S11 Fig. Tead-binding sites in Arg1 promoter. (A) Reported-Tead binding sequences (TBSs).
(B) Predicted TBSs in Arg1 promoter.
(PDF)
S12 Fig. YAP/TAZ-deficient macrophages exhibit reduced bactericidal activity. (A) Experi-
mental design of the bacterial killing assay. Briefly, BMDMs were infected with gram-negative
(E.coli) or gram-positive (L.monocytogenes) bacteria for 2 hours and after thoroughly washed,
incubated for 24 hours to determine the bactericidal activity of BMDMs derived from control
mice against YAP/TAZ-deficient mice. (B and C) YAP/TAZ-deficient BMDMs show reduced
bactericidal activity against E. coli ex vivo. (D) Nitric oxide (NO) production determined by
nitrite (NO2−) levels in conditioned medium of uninfected or E.coli infected control and YAP/
TAZ-deficient BMDMs. (E) The expression of pro-inflammatory genes involved in bacteri-
cidal activity was decreased in YAP/TAZ-deficient BMDMs after incubation with E. coli. n = 3
in each group. (F and G) YAP/TAZ-deficient BMDMs exhibit reduced bactericidal activity
against L.monocytogenes ex vivo. (H) Nitrite (NO2−) levels in conditioned medium of unin-
fected or L.monocytogenes infected control and YAP/TAZ-deficient BMDMs. (I) The expres-
sion of pro-inflammatory genes involved in bactericidal activity was decreased in YAP/TAZ-
deficient BMDMs after incubation with L.monocytogenes. For numerical raw data, please see
S1 Data.
(PDF)
S13 Fig. Macrophage-specific YAP overexpression exhibit enhanced bactericidal activity.
(A) Experimental design of the bacterial killing assay. Briefly, BMDMs were infected with
gram-negative (E.coli) or gram-positive (L.monocytogenes) bacteria for 2 hours and after thor-
oughly washed, incubated for 24 hours to determine the bactericidal activity of BMDMs
derived from control and YAP5SAmice. (B and C) YAP5SA BMDMs show increased bacteri-
cidal activity against E. coli and L.monocytogenes ex vivo, respectively. (D) NO production by
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BMDMs was determined by nitrite (NO2−) levels in conditioned medium. (E) The expression
of pro-inflammatory genes involved in bactericidal activity was enhanced in YAP5SA BMDMs
after incubation with E. coli or L.monocytogenes. n = 3 in each group. For numerical raw data,
please see S1 Data.
(PDF)
S14 Fig. Cardiac functional defects in control and YAP/TAZ-deficient mice 4 weeks post-
MI. Echocardiographic measurements of ventricular functional parameters at baseline and 4
weeks post-MI from control and YAP/TAZ-dKO mice: body weight (BW); and left ventricular
mass (LV Mass); left ventricular end-diastolic volume (LVEDV); and stroke volume (SV).
Data are shown as mean ± SEM (n = 4 to 7 per group). For numerical raw data, please see S1
Data.
(PDF)
S15 Fig. Neutrophil recruitment and migration are not affected due to YAP/TAZ deletion.
(A) Immunohistochemistry and quantification for MPO on control and YAP/TAZ-dKO
infarcted heart sections at 2 days post-MI. The number of MPO positive cells was determined
in�5 distinct microscope fields for each heart section. At least 4 hearts were analyzed for each
group. Scale bar represents 100 μm. (B) Migration of control and YAP/TAZ-dKO neutrophils
was examined by a transwell assay. Cells that had migrated to the lower chamber of the trans-
well plate were visualized by MPO immunostaining. DAPI was used to stain nuclei. Scale bar
100 μM. Quantification of MPO positive neutrophils from control and YAP/TAZ-dKO mice
migrated to the lower chamber of the transwell plate. For numerical raw data, please see S1
Data.
(PDF)
S16 Fig. Hypoxia induces YAP/TAZ expression in BMDMs. (A) BMDMs were isolated from
wild-type mice and exposed to hypoxia with H2O2 (100 μM) for 8 hours. Western blot analysis
for YAP, TAZ, and Nos2 was performed using total lysates from unstimulated and H2O2-stim-
ulated cells. Vinculin is shown as a loading control. (B) The relative protein expression of
YAP, TAZ, and Nos2 was quantified. For numerical raw data, please see S1 Data.
(PDF)
S17 Fig. Control and YAP/TAZ-dKO mice demonstrate equal size ischemic injury region
at 2 days post-MI. (A) Whole-mount images of control and mutant animals as indicated, 2
days post-MI. The white dotted line indicates the area of injury near the ligature. Scale bar
500 μM. Quantification of Ischemic area, (n = 3 per group). (B) Masson’s trichrome staining
and quantification of fibrosis on control and YAP/TAZ-dKO heart at 2 days post-MI. The area
was measured in 5� distinct microscope field, and the fibrotic area was normalized to the
remaining heart for each heart section. At least 3 hearts were analyzed for each group. For
numerical raw data, please see S1 Data.
(PDF)
S18 Fig. YAP/TAZ deletion leads to reduced interstitial fibrosis and hypertrophic response
post-MI. (A and B) Masson’s trichrome staining and quantification of interstitial myocardial
fibrosis on control and YAP/TAZ-dKO heart sections at 28 days post-MI. The area was mea-
sured in 5� distinct microscope field, and the fibrotic area was normalized to the remaining
heart for each heart section. At least 4 hearts were analyzed for each group. Scale bar represents
100 μm. (C and D) The cross-sectional area of the infarcted heart (border and remote zone)
from control and YAP/TAZ dKO mice at 28 days post-MI. The area was measured in�5 dis-
tinct microscope fields for each heart section. At least 3 hearts were analyzed for each group.
PLOS BIOLOGY Hippo pathway modulating macrophage polarization in injured heart
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000941 December 2, 2020 33 / 41
Scale bar represents 50 μm. (E) The expression of genes such asMyh7, Nppa, and Nppb
involved in hypertrophy was reduced in YAP/TAZ-dKO heart compared to control at 28 days
post-MI. n = 3 in each group. For numerical raw data, please see S1 Data.
(PDF)
S19 Fig. Improved revascularization in YAP/TAZ-dKO hearts post-MI. (A) Immunohis-
tochemistry and quantification for CD31 on control and YAP/TAZ-dKO heart sections at 28 days
post-MI. The area was measured in�3 distinct microscope fields for each heart section. At least 3
hearts were analyzed for each group. Scale bar represents 100 μm. (B) Increased capillary density
in YAP/TAZ-dKO heart at 28 days post-MI along with the corresponding quantification. At least 3
hearts were analyzed for each group. Scale bar 50 μM. For numerical raw data, please see S1 Data.
(PDF)
S20 Fig. FACS data for proinflammatory macrophage isolation from heart 2 days port-MI.
Gating strategies used for isolation of pro-inflammatory (iNOS+/F4/80+) macrophages from
the 2 days post-MI hearts.
(PDF)
S21 Fig. FACS data for reparative macrophage isolation from heart 6 days port-MI. Gating
strategies used for isolation of reparative (CD206+/F4/80+) macrophages from the 6 days
post-MI hearts.
(PDF)
S1 Data. Excel spreadsheet with numerical raw data underlying Fig 1A, 1B, 1C, 1D, 1E; Fig
2C, 2D, 2E; Fig 3A, 3B, 3E, 3G, 3F, 3H; Fig 4A, 4B, 4C, 4D, 4E, 4F, 4G, 4H, 4I, 4J, 4K, 4N,
4O, 4P, 4Q, 4R; Fig 5A, 5B, 5C, 5D, 5F, 5G, 5H, 5I, 5J; Fig 6B, 6D, 6E, 6F, 6G; Fig 7D, 7E,
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